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“Every body and every thing conspire to make me as contented as 
possible in it; yet I have seen too much of the vanity of human affairs, 
to expect felicity from the splendid scenes of public life. I am still 
determined to be cheerful and to be happy, in whatever situation I may 
be; for I have also learnt, from experience, that the greater part of our 
happiness or misery depends upon our dispositions, and not upon our 
circumstances. We carry the seeds of the one or the other about with 
us, in our minds, wheresoever we go” 
 
-Martha Washington
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Andri Thorarinsson, MD 
ABSTRACT	
Background: Breast cancer is the most common form of cancer in 
women worldwide. Although the incidence is increasing, the mortality 
rate is not. This results in a growing number of breast cancer survivors, 
and thereby in increasing demand for breast reconstructions. 
Complications after breast reconstructive surgery are common and can 
be caused by a wide range of factors, such as the reconstructive 
method, perioperative factors and patient-related factors. As the 
principal aim of breast reconstruction is to reverse the mastectomy 
deformity and restore body image and health-related quality of life 
(HR-QoL), traditional clinical outcome measures, such as medical or 
surgical complications, do not suffice assessing the values of different 
reconstruction methods for the patient. 
There are no established guidelines on choosing the best reconstruction 
method for the individual patient. However, patient perspectives and 
experiences are important when choosing the reconstructive method, 
and HR-QoL needs to be investigated in a systematic way when 
comparing different reconstruction methods. 
Aim: The aim of this thesis was to evaluate postoperative 
complications, to find independent risk factors for complications and 
compare HR-QoL between breast reconstruction patients, and with 
the general population.  
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Method: The four retrospective studies were based on a large 
database of breast reconstructions between the years 2003 and 2009 at 
the Department of Plastic Surgery, Sahlgrenska University Hospital, 
and the results of HR-QoL questionnaires from patients surgically 
treated with breast reconstruction during this time. 
Results: Paper I states the importance of a systematic and meticulous 
registration of complications in comparisons of different methods. The 
study revealed high complication rates with all of the methods, and the 
spectrum of complications was related to the operation method, where 
the DIEP group had the highest rate. The pattern of occurrence of 
complications ranged between early and late time points.  
Paper II shows the perioperative factors of duration of surgery and 
blood loss during surgery as independent risk factors for several 
postoperative complications, both early and late. 
Paper III shows several patient-related factors and adjuvant therapy as 
independent risk factors for complications, such as BMI, smoking, and 
radiotherapy. 
Paper IV shows that patients reconstructed with a DIEP flap are more 
satisfied with their reconstruction and overall outcome than patients in 
the other groups. 
Conclusion: Complications after breast reconstructive surgery are 
common and can be caused by many different factors. Patients 
reconstructed with a DIEP flap are more satisfied with their 
reconstruction than patients reconstructed with other methods. To 
maximize patient satisfaction, DIEP flaps should be more widely 
available, and complications rate after this type of surgery should be 
minimized. 
Keywords: breast cancer, breast reconstruction, surgical 
complications, health-related quality of life, perioperative risk factors, 
patient-related risk factors, DIEP flap, latissimus dorsi flap, lateral 
thoracodorsal flap, breast implants 
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SAMMANFATTNING	PÅ	SVENSKA	
Bakgrund: Bröstcancer är den vanligaste cancerformen hos världens 
kvinnor, incidensen ökar, men dödligheten är stabil. Detta resulterar i 
ett växande antal patienter som har överlevt sin bröstcancer, och 
därmed en ökad efterfrågan på bröstrekonstruktioner. Komplikationer 
efter bröstrekonstruktion är vanliga och kan orsakas av ett flertal 
faktorer, såsom den rekonstruktiva metoden, perioperativa faktorer och 
patientrelaterade faktorer. Eftersom det huvudsakliga syftet med 
bröstrekonstruktion är att återskapa bröstformen, förbättra självbilden 
och normalisera hälsorelaterad livskvalitet, är traditionella kliniska 
mått, såsom medicinska eller kirurgiska komplikationer, otillräckliga för 
att bedöma värdet av olika rekonstruktionsmetoder för patienten. 
Patientens perspektiv är mycket viktigt inför val av metod och 
hälsorelaterad livskvalitet behöver utvärderas på ett systematiskt sätt, 
vid jämförelse av olika rekonstruktionsmetoder. 
Syfte: Syftet med denna avhandling är att utvärdera och jämföra 
komplikationer vid bröstrekonstruktiv kirurgi, hitta oberoende 
riskfaktorer för postoperativa komplikationer och jämföra 
hälsorelaterad livskvalitet mellan de fyra vanligaste 
rekonstruktionsmetoderna som används vid Verksamhetsområde 
plastikkirurgi, Sahlgrenska Universitetssjukhuset i Göteborg. 
Metod: Data för denna avhandling har hämtats från en 
specialframtagen databas för bröstrekonstruktioner utförda mellan 
2003 till 2009, och resultaten för den hälsorelaterade livskvaliteten från 
inskickade frågeformulär från patienter som opererats under 
studietiden. 
Resultat: Den första studien fastställer vikten av en systematisk och 
noggrann registrering av komplikationer vid jämförelse av olika 
rekonstruktionsmetoder. Studien visade höga komplikationsfrekvenser 
för alla metoder, och spektrumet av komplikationer var relaterat till 
den rekonstruktiva metoden. Mönstret för komplikationer varierade 
mellan tidiga och sena tidpunkter. 
Den andra studien visade att två perioperativa faktorer, operationstid 
och blodförlust under operation, är oberoende riskfaktorer för flera 
postoperativa komplikationer, både tidiga och sena. 
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Den tredje studien visade att flera patientrelaterade faktorer var 
oberoende riskfaktorer för komplikationer, såsom BMI, rökning och 
strålbehandling. 
Den fjärde studien undersökte hälsorelaterad livskvalitet efter 
bröstrekonstruktion. Studien beskriver att patienter som rekonstruerats 
med DIEP lambå är mer nöjda med känslan av sitt bröst och det 
generella resultatet än patienter som är opererade med andra metoder. 
Slutsatser: Komplikationer efter bröstrekonstruktioner är vanliga och 
kan orsakas av många olika faktorer. Patienter, rekonstruerade med 
DIEP lambå är mer nöjda med sin rekonstruktion än patienter 
rekonstruerade med andra metoder. För att maximera vinsten i 
hälsorelatedad livskvalitet, bör DIEP lambåer vara mer tillgängliga, 
och komplikationer efter denna typ av kirurgi bör minimeras. 
Nyckelord: bröstcancer, bröstrekonstruktion, postoperativa 
komplikationer, hälsorelaterad livskvalitet, peroperativa riskfaktorer, 
patientrelaterade riskfaktorer, DIEP lambå, latissimus dorsi lambå, 
implantatrekonstruktion, bröstimplantat 
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SAMANTEKT	Á	ÍSLENSKU	
Bakgrunnur: Brjóstakrabbamein er algengasta krabbamein meðal 
kvenna í heiminum. Nýgengi eykst, en dánartíðni í hinum vestræna 
heimi helst stöðug. Þetta leiðir til vaxandi fjölda eftirlifandi sjúklinga, 
og þar með aukinnar eftirspurnar eftir brjóstauppbyggingum. 
Fylgikvillar eftir brjóstauppbyggingar eru algengir og geta stafað af 
ýmsum orsökum, t.d. þeirri aðferð sem notuð er við uppbygginguna, af 
skurðtæknilegum þáttum og persónubundnum þáttum. Þar sem 
megintilgangur brjóstauppbyggingar er að endurheimta lögun 
brjóstsins, bæta sjálfsmynd og heilsutengd lífsgæði, er viðhorf 
sjúklingsins mikilvæg við val á uppbyggingaraðferð. Heilsutengd 
lífsgæði þarf að mæla á kerfisbundinn hátt við samanburð á aðferðum 
til brjóstauppbygginga. 
Markmið: Markmið þessarar ritgerðar er að meta og bera saman 
fylgikvilla brjóstauppbygginga, finna sjálfstæða áhættuþætti fyrir 
fylgikvilla og bera saman heilsutengd lífsgæði milli fjögurra algengustu 
brjóstauppbyggingaraðferða sem notaðar eru við Lýtalækningadeild 
Sahlgrenska háskólasjúkrahússins í Gautaborg. 
Aðferðir: Gögnum var safnað í sérhannaðan gagnagrunn fyrir allar 
brjóstauppbyggingar framkvæmdar á árunum 2003 til 2009. 
Heilsutengd lífsgæði voru mæld með viðurkenndum spurningalistum. 
Niðurstöður: Fyrsta rannsóknin varpar ljósi á mikilvægi 
kerfisbundinnar og nákvæmrar skráningar á fylgikvillum við 
samanburð á uppbyggingaraðferðum. Rannsóknin sýndi háa tíðni 
fylgikvilla, að tegund þeirra tengdist uppbyggingaraðferðinni og að 
mynstur þeirra var ólíkt hvort sem um var að ræða snemma eða seint í 
uppbyggingarferlinu. 
Önnur rannsóknin sýndi að tveir skurðtæknilegir þættir, blóðtap og 
skurðtími eru sjálfstæðir áhættuþættir fyrir marga fylgikvilla, bæði 
snemm- og seinkomna. 
Þriðja rannsóknin sýndi ákveðna persónubundna þætti sem sjálfstæða 
áhættuþætti fyrir fylgikvilla, svo sem þyngdarstuðul (BMI), reykingar, 
og geislameðferð. 
Fjórða rannsóknin bar saman heilsutengd lífsgæði milli mismunandi 
uppbyggingaraðferða. Hún sýndi að sjúklingar sem fengið hafa 
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uppbyggingu með DIEP flipa eru ánægðari með uppbygginguna en 
aðrir hópar. 
Ályktanir: Fylgikvillar eftir brjóstauppbyggingu eru algengir og geta 
stafað af mörgum þáttum. Til að hámarka ávinning í heilsutengdum 
lífsgæðum ættu DIEP flipar verða aðgengilegri vinna skal markvisst að 
því að halda fylgikvillum í lágmarki. 
Leitarorð: brjóstakrabbamein, brjóstauppbygging, fylgikvillar eftir 
aðgerð, heilsutengd lífsgæði, skurðtæknilegir áhættuþættir, 
sjúklingatengdir áhættuþættir, DIEP flipi, latissimus dorsi flipi, lateral 
thoracodorsal flipi, brjóstauppbygging með brjóstapúðum.     
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ABBREVIATIONS	
Ais Aromatase inhibitors 
ANOVA Analysis of variance 
AUC Area under the curve 
BMI Body mass index 
BRCA Breast cancer susceptibility gene 
CC  Creative commons 
CI Confidence interval 
DI Direct implant 
DIEP Deep inferior epigastric artery perforator 
DVT Deep vein thrombosis 
EQ-5D EuroQol five dimensions questionnaire 
EXP Expander / implant 
HR-QoL Health-related quality of life 
LD Latissimus dorsi 
LSD Least significant difference 
LTDF Lateral thoracodorsal flap 
NAC Nipple/areola complex 
OR Odds ratio 
PGWB The Psychological General Well-Being Index 
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PROM Patient reported outcome measure 
PRS Plastic and Reconstructive Surgery journal 
SD Standard deviation 
SF-36 Short form 36 health survey 
SPSS Statistical Package for the Social Sciences 
TRAM Transverse rectus abdominis muscle 
VAS Visual analogue scale 
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DEFINITIONS	IN	SHORT	
Dependent variable 
A variable whose value depends on that 
of another variable. 
Domain of PROM 
The condition, skills or abilities being 
measured by a questionnaire or PROM. 
Independent variable 
A variable whose variation does not 
depend on that of another variable. 
Latent variable 
 An underlying construct that is not 
measured directly but rather through 
several items in a PROM measure 
reflecting that construct. 
Rasch measurements 
A statistical method of measurements of 
latent traits, like attitude or ability. Used 
in scoring of the Breast-Q questionnaire. 
Reliability 
The overall consistency of a measure. 
The degree to which test scores are 
consistent from one test administration 
to the next. 
Type I error 
The incorrect rejection of a true null 
hypothesis; false positive results. 
Validity 
The extent to which a concept, 
conclusion or measurement corresponds 
accurately to the real world. 
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1 INTRODUCTION	
 
Breast	cancer	
Breast cancer is the most common invasive cancer in women. It 
accounts for 22.9% of all invasive cancers in the female population.1,2 
Most cases of breast cancer are sporadic, however, approximately 2-
3% of breast cancers are genetic, caused by the breast cancer genes 
BRCA1 and 2.3,4 Certain gene mutations associated with breast cancer 
are more common among certain geographic or ethnic groups, such as 
Ashkenazi Jews and people of Icelandic, Norwegian and Dutch 
ancestry.5 
The incidence and mortality of breast cancer is increasing in 
developing countries, although in Europe and North America the 
mortality rate is stable or slightly decreasing.6-10 In Sweden, the 
incidence has more than doubled since 1958, when the cancer registry 
of the National Board of Health and Welfare started.11 As treatment 
modalities have improved, about 90% of women in the USA survive 
for at least five years after the diagnosis,12 which increases demand for 
breast reconstructions.13,14 Breast reconstructions are therefore 
becoming more frequent,15,16 and in Gothenburg, Sweden, 
approximately 40% of women undergo breast reconstruction after 
mastectomy.17 
A third of women treated with mastectomy have persistent 
psychosocial morbidity, with reduced self-esteem, insomnia, increased 
anxiety, depression, disturbed body image and/or sexual problems.18-21 
Both primary and secondary breast reconstructions benefit the patient 
in terms of increased self-esteem and health-related quality of life (HR-
QoL) compared with no reconstruction.22-25 
Different methods are used for breast reconstruction, and the preferred 
method varies between centres and surgeons. At Sahlgrenska 
University Hospital, Gothenburg, five different surgical treatments 
have mainly been used: (1) deep inferior epigastric perforator flap 
(DIEP),26 (2) latissimus dorsi flap (LD),27 (3) lateral thoracodorsal flap 
with silicone implant (LTDF),28 (4) tissue expander with a secondary 
silicone implant (EXP),29 and, when soft tissue permits (5) direct 
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augmentation with silicone implant (DI), however, this method was 
abandoned after 2009.  
 
Breast	cancer	treatment	
	
Surgery	
Surgery is always a part of treatment for breast cancer. The American 
surgeon William Halsted performed the first radical mastectomy in 
1892, and proved this method to be the best treatment of breast cancer 
at the time. Halsted’s report from 1894, which summarized the 
outcome for the first 50 cases, showed better results than any 
previously published data. The axillary lymph nodes and both the 
pectoralis major and minor were excised en bloc, and the defect was 
reconstructed with a skin transplant (Figure 1). It should be noted that 
when Halsted began the radical mastectomy era, breast cancer was 
basically incurable. Radical mastectomy, therefore, became the 
therapy of choice. Nevertheless, some women refused this treatment 
due to the postoperative deformation of the chest. 
Radical mastectomies were carried out until the 1970s. As late as 1972, 
it was used to treat 47.9% of breast cancer patients in the USA. It 
would later gave way for modified radical mastectomy and, later, 
breast conserving therapy.30 
In the early 1930s, the modified radical mastectomy was introduced. 
The pectoralis major was spared, but all the skin was excised, and the 
defect was still reconstructed with a skin graft. In the 1950s and later 
on, many studies compared the results of radical mastectomy and 
modified radical mastectomy, and found no difference in cure rates. 
Later research showed no difference in cure rates between modified 
radical mastectomy and lumpectomy with radiotherapy, thus paving 
the way for breast-conserving therapy. 28 
In Europe and the USA, as in Gothenburg, about half of the patients 
diagnosed with breast cancer choose breast-conserving therapy with 
lumpectomy and radiotherapy.17 
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Adjuvant	therapy	
aThe use of cytotoxic chemotherapy is common, in both the early and 
late stages of breast cancer. Despite better understanding of the use of 
adjuvant treatment in the early stages, the treatment of metastatic 
disease has not come as far. However, while being incurable, 
metastatic disease is often sensitive to chemotherapy, especially early in 
the disease process. 
Radiotherapy after breast cancer is comparable to surgery in that it is a 
local treatment. It is used together with breast-conserving surgery to 
limit the surgical defect or if the tumour is large or of an aggressive 
nature. The target of radiotherapy is the breast area, with or without 
the thoracic wall, and/or the axillary lymph nodes. Radiotherapy 
significantly decreases the risk for local and regional recurrence 
especially in patients with tumours that are liable to reoccur.31,32 
                                                
a Author: William Stewart Halsted. From: http://wellcomeimages.org/ indexplus/image 
/L0004968.html. Licence: CC-BY 4.0 
Figure 1: A Halsted mastectomya 
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Breast cancer cells can have receptors for hormones, such as oestrogen 
or progesterone. Oestrogen binds to these receptors stimulating cell 
proliferation. If the receptors are blocked or the levels of oestrogen are 
minimized, cancer growth may be slowed down or even stopped. Two 
types of medication are used as adjuvant hormone therapy: oestrogen 
receptor blockers (tamoxifen) and aromatase inhibitors (AIs). 
Tamoxifen inhibits oestrogen receptors in cancer cells,33 while AIs 
block the capability of the aromatase enzyme to produce oestrogen and 
is more commonly used in postmenopausal women.34 
 
Breast	reconstructions	
 
Flaps	
The first documented breast reconstruction was conducted in 1895, 
when Vincent Czerny, professor of surgery in Heidelberg, Germany, 
transplanted a large lipoma to the thoracic wall, replacing the 
mastectomized breast. Breast reconstructions were avoided for a long 
time because of Halsted’s opposition. He argued that breast cancer was 
a regional entity, and if breast reconstruction was done it would be a 
"violation of the local control of the disease."35-37 Several techniques 
were introduced during the first half of last century using “walking” 
tube flaps, either from the contralateral breast or the abdomen. Sir 
Harold Gilles used a flap from the abdomen when performing his first 
breast reconstruction in 1942. However, the technique was associated 
with multiple procedures, extensive donor site morbidity, and 
occasional flap failures.35,36  
 
The	latissimus	dorsi	flap	
In 1979, the LD flap was introduced for single stage reconstruction of 
mastectomy defects.27,38 During the procedure, the patient is first 
placed in the lateral decubitus position. Incisions are made round a 
skin island in the back. Then, the entire latissimus dorsi muscle is 
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dissected free from its origin 
at the iliac spine and the 
vertebrae, while the 
humeral attachments of the 
muscle are left intact along 
with its thoracodorsal 
vessels and nerve. Some 
surgeons dissect the 
thoracodorsal nerve and 
divide it in order to decrease 
the risk for breast animation 
postoperatively. A tunnel is 
made from the mastectomy 
scar to the axilla and the 
flap is then transferred to 
the front. The patient is 
then turned to the supine 
position and the breast is 
reconstructed in 
combination with a silicone 
implant (Figure 2).  
The LD flap remains a 
workhorse flap in 
reconstructive breast 
surgery, despite the 
incidence of donor-site 
morbidity.27,39  
 	
Figure 2: The latissimus dorsi flap 
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The	lateral	thoracodorsal	flap	
The LTDF was first 
published in 1986 in the 
Plastic and 
Reconstructive Surgery 
(PRS) journal.28 The flap 
can be used in both 
primary and secondary 
breast reconstruction 
with or without an 
implant. It is considered 
a one stage procedure, 
with an implant after 
mastectomy, but can also 
be used to reconstruct 
lateral defects of breasts 
after large lumpectomies 
without an implant.40,41 
The flap is designed 
laterally of the mastectomy area, with its inferior border a few 
centimetres under the new inframammary fold. The flap is then raised, 
making sure the deep muscle fascia is included in the flap, and is 
rotated from a horizontal to a vertical position, thereby adding the 
tissue of the flap to the mastectomy site. A pocket is then dissected 
under the pectoralis major muscle, which is released from its inferior 
attachment. Finally, an implant is placed under the muscle (Figure 3). 
 
The	TRAM	flap	
The pedicled TRAM flap was introduced in 1982.42 It is widely used 
and remains a workhorse flap for autologous breast reconstructions in 
many centres.35 During the procedure, all skin and fat from the 
umbilicus to the pubis bone is dissected free from the muscle fascia, 
except for one side of the rectus abdominis muscle, where the 
perforating vessels enter the subcutaneous tissue from the epigastrica 
profunda through the muscle. The rectus abdominis is divided 
inferiorly and the muscle is dissected free from the deep muscle fascia. 
Figure 3: The thoracodorsal flap 
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This way, the muscle acts as a pedicle for the flap tissue. The flap is 
then tunnelled to the breast area and shaped as a breast. 
Refinements of the TRAM flap lead to the development of the muscle 
sparing free TRAM, in which a small segment of the rectus abdominis 
muscle is included in the flap, the vessels are cut and a microsurgical 
anastomosis is carried out at the recipient site.43 
 
The	DIEP	flap	
Later, the DIEP flap was introduced, in which no muscle is included 
and the motor nerves to the rectus abdominis muscle are retained.44,45 
A DIEP flap procedure involves two surgical teams. One team opens 
the mastectomy scar, identifies rib III or IV, resects the rib cartilage 
and isolates the mammaria interna vessels. The other team dissects the 
perforator through the rectus abdominis muscle, and follows the deep 
inferior epigastrica profunda vessels down to the inguinal area. The 
vessels are then ligated, the flap is usually rotated 180° and the vessels 
are microsurgically anastomosed to the mammaria vessels. The tissue is 
then shaped to the new breast (Figure 4). 
Figure 4: The DIEP flap 
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Studies have shown that DIEP flaps have slightly higher risk of flap 
necrosis compared with the TRAM flaps, but the TRAM flaps have 
higher risk of abdominal complications.46 Reports state that patients 
receiving a DIEP reconstruction, are more satisfied compared with 
patients receiving an implant based reconstruction.47,48 
 
Other	flaps	(TFL,	SGAP,	IGAP,	TUG	flap)	
Several other free flaps have been introduced for breast reconstruction. 
The tensor fascia lata (TFL),49 superior gluteal flap (SGAP),50 inferior 
gluteal flap (IGAP),51 transverse upper gracillis flap (TUG)52 and 
Reuben´s flap are examples.36 These flaps are not as widely used due to 
the need for complicated positioning of the patient during the surgery. 
For unilateral reconstructions, the donor sites for these flaps are not 
symmetrical and can therefore cause deformities. 
 
Breast	reconstructions	–	Implants	
The first attempts to perform autologous breast reconstructions were 
associated with difficulties and often caused considerable donor-site 
morbidity. As a result, there has been substantial interest in synthetic 
materials that could be used for breast reconstruction.  
Prosthetic materials have many advantages and have a long history. 
Many different materials have been adopted, but few have gained 
popularity. Robert Gersuny, an Austrian surgeon, was the first who 
tried to augment a breast with paraffin in 1889.37 Other examples of 
materials that have been used are petroleum jelly, vegetable oils, 
lanolin, ivory, ox cartilage, ground rubber, terylene wool, gutta-percha, 
polyethylene chips, polyethylene tape, silastic rubber, polyurethane 
foam sponges, beeswax, glass balls, teflon- silicone prosthesis and 
Ivalon gauzes.36 These materials frequently cause an immunological 
reaction, and serious complications, such as lung emboli, skin necrosis, 
chronic infections and extensive scar tissue.37   
The silicone implant was first introduced by Cronin and Gerow in 
1961 and was first used for breast augmentation in 1962. However, 
silicone implants did not achieve early popularity for breast 
reconstructions since most breast cancer patients had a defect after a 
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Halsted radical mastectomy.36 The first generation of implants in the 
1960s had a thick and durable untextured shell and high viscosity gel. 
Many patients found these implants inflexible. In the second 
generation implants, introduced in the 1980s, the shell was thinner and 
softer and the silicone gel had lower viscosity. Because of the softness, a 
shorter incision was possible and the augmented breast was soft. 
However, if the implant ruptured, the gel leaked out causing 
granuloma formation and foreign body immunological reactions. 
Therefore, the third generation of implants had a thicker shell again, 
and higher gel viscosity.37 
Breast reconstructions with implants were initially performed as a one-
stage procedure. This changed in the early 1990s when tissue 
expanders were introduced. This gave opportunity for both primary 
and secondary breast reconstruction with more flexibility to choose the 
size and shape of the reconstructed breast. However, in this major 
advantage lies a significant weakness; an expander reconstruction is 
always a two-stage procedure.  
Implant reconstruction with an expander followed by a permanent 
implant is the most common method for breast reconstruction at the 
Department of Plastic Surgery, Sahlgrenska. In the first stage, an 
incision in the mastectomy scar is made, a pocket under the pectoralis 
major muscle is dissected and the origin of the muscle inferiorly and 
the lowest quarter of the sternal attachment is released. The low height 
tissue expander is then inserted and gradually filled with saline during 
Figure 5: An expander and an implant 
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the following weeks. After a three-month waiting period, the expander 
is replaced with a permanent implant (Figure 5). 
 
Complications	after	breast	
reconstruction	
 
Complications after breast reconstruction are common, consume 
considerable resources every year53-62 and affect the patient’s emotional 
well-being and level of satisfaction.57,63-66 Many suffer from possibly 
avoidable complications. Patient satisfaction and health-related quality 
of life are frequent parameters in outcome measurement in plastic 
surgery. This emphasizes the importance of efforts to identify and 
reduce the possible risks for complications. 
The risk for complications can be related to several factors. The 
surgical method itself is of importance since different methods have 
different spectra of complications.67 The selection of patients is also of 
importance where certain patient characteristics (e.g. age, smoking 
habits, obesity, and adjuvant cancer therapy) must be 
considered.54,58,68-72 Once the individualized choice of reconstruction 
method is made, the surgical procedure must be optimized with respect 
to perioperative factors such as the duration of surgery, blood loss and 
skills of the surgeon. 
 
The	choice	of	method	as	a	risk	factor	for	
complications	
In order to better understand and compare the frequency of different 
complications between different breast reconstruction methods, it is 
important to use the same definitions of complications. However, there 
is a need for studies that systematically investigate and compare the 
incidence of complications in different reconstruction methods where 
the same definitions for complications are used. Studies on the 
frequency of complications after breast reconstruction have mostly 
compared inadequate numbers of surgical methods and included 
limited numbers of patients.45,55,57,73-89 
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Perioperative	factors	
Studies show that prolonged duration of surgery is a risk factor for 
tissue expander loss,90,91 increases risk for unplanned admission after 
ambulatory plastic surgery92 and has a high correlation with other 
complications, such as fat necrosis, skin necrosis and infection.93,94 
Other studies have failed to show a relationship between duration of 
surgery and hematoma,95 or other postoperative complications, such as 
wound complications, flap failure, thromboembolism or respiratory 
complications.96-99 On the other hand, a study by Rambachan and co-
workers shows that the duration of surgery, measured in 30 minute 
intervals, is an independent risk factor for complications but that it 
does not affect mortality.94 
Studies of blood loss in the field of plastic surgery are few. Regarding 
breast reconstruction, one study shows no correlation between several 
patient characteristics and blood loss.93 However, another study, 
analysing the relationship between perioperative blood transfusion and 
complications, finds a strong correlation, but blood loss is not directly 
studied.75 
It has been established that more experienced surgeons have lower 
complication rates, both in plastic surgery and in other specialities.100-
102 
 
Patient-related	factors	
Several studies have examined the relationship between patient 
characteristics and complications,54,58,69-72 but the results are not 
conclusive. 
Radiotherapy has been shown to adversely affect outcomes after an 
implant-based reconstruction, with increased late failure rates,57,68,103 
poor aesthetic results, loss of symmetry,104-106 capsular contraction and 
infection, even with the latest generation of implants and modern 
radiotherapy.57,61,68,85,103,105,107-113 However, the results from studies on 
radiotherapy and autologous reconstructions are more conflicting. 
Certain studies find that radiotherapy of a breast reconstructed with a 
DIEP or a TRAM flap has no effect,114,115 while others show a 
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considerable negative effect on the final results.113,116-121 
Reconstruction with autologous tissue in an irradiated patient does not 
seem to increase the risk for adverse events.47 
Studies on the effect of chemotherapy on complications after delayed 
reconstructions are scarce, and not in agreement. On one hand, 
adjuvant chemotherapy is reported to be associated with a higher rate 
of complications and reconstruction failure than radiotherapy,109 and 
another study shows a trend towards more complications in TRAM 
flaps in patients who have had chemotherapy.53 A third study shows an 
association between preoperative chemotherapy and infection during 
expansion.122 On the other hand, several other studies show no 
association between adjuvant chemotherapy and adverse events after 
breast reconstruction.82,103,123 Preoperative chemotherapy has also 
been shown to decrease satisfaction with breast(s), measured with the 
Breast-Q questionnaire.100 
There is no general agreement on whether adjuvant hormone therapy 
increases the risk for complications or not. Some studies show an 
association with overall complications,124 especially capsular 
contraction,107,125 while other studies have shown no such 
association.109,126-129 
It is well established that high BMI increases the risk for surgical 
complications and overall morbidity. This is true for both the donor 
and recipient sites, for both implant and autologous reconstruction, for 
immediate and late reconstruction and for the use of an acellular 
dermal matrix.77,80,84,90,122,130-135 A high BMI also has an association 
with adverse effect on body image after prophylactic mastectomy with 
immediate breast reconstruction.136 While general satisfaction is not 
decreased in obese patients undergoing an implant based breast 
reconstruction, they have less aesthetic satisfaction. This difference is 
not seen in patients undergoing autologous reconstruction.136-138 
It is well established that smoking can have a detrimental effect on free 
flap breast reconstruction,45,58,59,72,87,139,140 even if some studies have 
failed to find this relationship.43,56,141,142 The same seems to be true for 
implant based reconstructions,71,82,88,107,143,144 even if not all studies 
confirm the findings.122 
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Numerous studies show no relationship between age and risk for 
complications,43,45,72,96,141,142,145-149 while some other studies show that 
elderly patients have increased risks.71,90,143 
Diabetes has been associated with postoperative complications after 
autologous reconstruction; however, the results after implant-based 
breast reconstruction are more conflicting.47,122,150,151 Noninsulin-
dependent diabetes is associated with surgical complications, both in 
autologous and implant reconstructions. Insulin-dependent diabetes is 
associated with medical and overall complications.169 However, other 
studies have failed to find any association between diabetes and any 
postoperative complications.152 
 
Other	patient-related	factors	
Patients with renal disease seem to be prone to postoperative 
complications in plastic surgery.151,153 Very little has been written on 
the relationship between a history of DVT and postoperative 
complications, but one study shows an increased risk for thrombosis 
after free flap surgery in hypercoagulative patients and a very low 
salvage rate of the flaps.154 Some studies have shown a connection 
between silicone implants and several rheumatic- and neurologic 
diseases155; however, most studies have shown the opposite.156-159 
	
Health-related	quality	of	life	
 
Science has always focused on measurable variables such as mortality 
and morbidity. With better technology, researchers have been able to 
measure objective variables with greater precision. This has led to 
considerable advances in treatment options for different diseases.160 
However, traditional measures have still not been able to measure 
important subjective psychological experiences, such as satisfaction 
with life, social relations, security, commitment and interests in the 
future.161 Traditional measurements are also insufficient at evaluating 
very common diseases like most mental illnesses.161 The relationship 
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between medical, objective measurements and subjective experiences 
are often weak or non-existent.162 
Modern medical care can consume almost unlimited resources. The 
demand for prioritizing different treatments or examinations is 
increasing, and resources need to be allocated where they benefit as 
many people as possible.163 For this to become reality, traditional, 
objective measurements are inadequate.160 
The conditions for measurements of HR-QoL are: 
 A well-defined concept or phenomenon to be investigated 
 A group of patients or other subjects of interest 
 A HR-QoL instrument to measure the concept of interest164 
There is a vast number of instruments for measuring HR-QoL, which 
can be classified into either generic or disease-specific.165,166 The 
generic ones, such as the SF-36, are aimed at a wide range of patients 
regardless of age or health status, and are intended to be relevant to the 
general population.167 However, they are insensitive when studying 
subgroups or how certain conditions change over time. The specific 
ones are oriented towards a specific disease or treatment and can more 
precisely measure conditions of smaller groups where a general 
instrument would not show significant change.168-170 On the other 
hand, the disease-specific questionnaires cannot measure general 
health in a large population of people. 
If the intention is to draw conclusions for a larger group than only the 
group answering the questionnaire, the instrument needs to be 
sensitive, reliable and valid.171 
Although life-saving interventions sometimes occur in reconstructive 
plastic surgery, the primary goal is to improve the patients' quality of 
life. It is relatively easy to measure certain variables, such as amount of 
breast tissue surgically removed or relapse of skin tumours in the face, 
but it also is essential to measure changes in HR-QoL when evaluating 
the results of a given treatment.172 
All HR-QoL questionnaires are composed of multiple questions that 
are selected by a validity process. None of the individual items can 
directly measure the variable of interest. Therefore, no single HR-QoL 
instrument can be the best instrument in all situations. This is 
particularly true in plastic surgery. 
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Questionnaires	
 
General	information	on	PROMs	
Psychometrics is the discipline in psychology that deals with design, 
administration and interpretation of quantitative tests for the 
measurement of psychological variables.173 Psychometrics use patient-
reported outcome measures (PROMs) as an instrument for measuring 
the subject of interest. 
PROMs are a broad concept, which may include terms such as fatigue, 
depression or pain or physical symptoms like nausea and 
vomiting.174,175 A PROM consists of one or more items. An item is a 
question whose answer is the manifestation of an underlying variable 
or construct,174 which is of interest for the researchers. Several items 
reflecting one construct are often used to increase reliability. Scales are 
then constructed from the responses of the collection of items. They are 
intended to reveal the level of an underlying variable, which is not 
readily observable by direct questions.176 A questionnaire can consist of 
several scales and items (Figure 6). 
Each question in an HR-QoL questionnaire is an expression for each 
item. Some of these items can be simple assessments of HR-QoL 
related issues, such as a physical symptom. Other HR-QoL concepts of 
interest are more complex, and frequently it is necessary to use several 
items, which in combination can shed light on the concept of interest, 
the so-called latent variable. The latent variable is a construct that 
cannot be directly measured by a single observable variable or item. It 
is rather indirectly measured with multiple items in a multi-item 
scale.177 
Some psychological aspects of HR-QoL have a definite, explicit, and 
universally agreed definition. Example of this is stress, which manifests 
in both physiological and psychological symptoms. Other psychological 
aspects can be argumentative, and it may even be debated whether the 
psychological concept really exists as a separate concept or entity that 
can be measured. An example of this can be measurements of a 
fulfilling life or the perceived degree of autonomy in life. 
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Difficulties in collecting data and getting patients to answer 
questionnaires are common in clinical trials.178 Bias in the results of the 
PROM may arise due to missing data, either because the responders 
skip certain questions or do not follow the instructions given by the 
researchers.166 If the missing data is systematic, e.g. many responders 
omit the same question, the results of the PROM cannot be 
representative of the entire group, but only of the group that answers 
the question. The consequences are, that the results of the study cannot 
be considered reliable. However, if the missing data can be considered 
as entirely random, then the analyses performed on the data may not 
be biased, but are dependent on the number of responses. 
If the group of responders is large enough, there is the possibility of 
discovering minimal changes in the average level of HR-QoL; 
miniscule changes that are of little relevance to the individual 
patient.166 If, however, the group of responders is small, there have to 
be considerable changes in the PROM to be able to obtain statistically 
significant results.179 
Figure 6: The usual construction of a patient-reported outcome measure 
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SF-36	
The SF-36 is a Short-Form health questionnaire constructed of 36 items. 
The 36 items are brought together in 8 functional health and well-
being domains (Figure 7). The scales are then aggregated into two 
summary measures of Physical health and Mental health. Each item 
belongs to only one scale. Three of the domains (PF, RP, and BP) 
correlate highly with the physical health and contribute the most to the 
Physical Component Summary (PCS) scale. Three of the domains (SF, RE 
and MH) highly correlate with mental health and contribute the most 
to the Mental Component Summary (MCS) scale. Two of the scales (GH and 
VT) have a good correlation with both PCS and MCS.167,180 SF-36 is a 
generic PROM, intended for large populations.181 
 
EuroQol	five	dimensions	questionnaire	(EQ-5D)	
The primary objective in the development of EQ-5D was to develop a 
scale that would be general and not specific to a certain disease.182 It 
consists of five general questions: mobility, self-care, usual activities, 
Figure 7: The structure of SF-36 
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pain/discomfort and anxiety/depression. Each question has three levels: no 
problem, some problem or a significant problem. On the second page 
of the questionnaire is a 20 cm vertical, visual analogue scale (VAS) 
where at the top is "best imaginable health state" and at the bottom is 
"worst imaginable health state." The VAS scale gives quantitative 
information that can be used as a measure of health outcome for the 
responders. 
The EQ-5D has been extensively used in both general populations and 
patient samples. Since three levels are used for each dimension, the 
scale has been criticized for "ceiling effects," i.e. not being able to 
measure small differences in health states or in patients with mild 
conditions. As a response to this criticism, the new, more detailed scale 
has been designed with five levels; having no problems, having slight 
problems, having moderate problems, having severe problems, and 
being unable to do/having extreme problems.183 
The EQ-5D has been used for breast cancer patients.184 It is 
infrequently used as a single scale, but usually in combination with 
other more specific PROM scales. 
 
The	Psychological	General	Well-Being	Index	(PGWB)	
PGWB measures the subjective perception of psychological general 
well-being and psychological symptoms. It is used to assess 
psychological well-being and quality of life in large groups and patients 
with chronic diseases. It is composed of 22 items and includes six 
dimensions: anxiety, depressed mood, positive well-being, self-control, general 
health and vitality.185 A Swedish version has been developed,186 and 
values for the general population are available. Analysis of general 
populations has shown that women have a lower score than men.187 
The PGWB is considered to be useful to assess the differences between 
different types of treatment. However, it does not detect clinically 
meaningful differences in well-being as sensitively as a disease-specific 
PROM. Therefore, it is often appropriate to use the PGWB in 
combination with other specific questionnaires.185 
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The	Breast-Q	
Pusic et al. published a review article in 2007 examining 223 PROMs 
in plastic surgery and showed that only 7 of them met criteria of 
psychometric evidence for use in patients having breast surgery.188 One 
of the modules of the Breast-Q questionnaires was specially developed 
and validated using a meticulous methodology with focus groups, 
expert panels, patient interviews, and detailed literature reviews to 
evaluate outcome after breast reconstruction. This includes the use of 
Rasch measurement methods and building scales from the perspective 
of psychometric analyses.189,190 
In the development of Breast-Q, the aim was to construct a model 
which could capture the entire reconstructive process and obtain a 
representative picture of the patient’s whole experience, both in terms 
of the effect on HR-QoL and satisfaction with the results (Figure 
8).191,192 
The Breast-Q is built on two underlying themes: HR-QoL and patient 
satisfaction. Each of these have the subthemes of physical, psychosocial 
and sexual well-being, and satisfaction with care, satisfaction with breasts and 
Figure 8: The structure of Breast-Q 
Th
e 
11
6 
ite
m
s 
of
 B
re
as
t-
Q
Physical well-being
Psychosocial well-being
Sexual well-being
Satisfaction with care
Satisfaction with breasts
Satisfaction with overall 
outcome
Health-
related 
quality of life
Patient 
satisfaction
Q. 3
Q. 6
.....
Q. 6
…..
Q. 2
Q. 116
Q. 4
Q. 5
etc…
…..
…..
…..
Q. 1
Q. 3
Andri Thorarinsson, MD 
 
31 
 
satisfaction with overall outcome.193 The Breast-Q questionnaire scales are 
developed from the subthemes.194 It is not necessary to use all the 
scales of Breast-Q at once. There is the possibility of using one or a few 
of the scales, for example if the focus is on measuring the quality of 
care provided by the office staff.191 
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2 AIMS	
The aims of this thesis are: 
1. To systematically examine complications after breast reconstruction 
with regard to each of the reconstructive methods used. 
2. To find independent perioperative risk factors for complications. 
3. To find independent patient-related risk factors for complications. 
 4. To examine the effect of breast reconstruction on health related 
quality of life 
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3 PATIENTS	AND	METHODS	
	
Study	samples	
 
A list of all patients who had undergone any type of breast 
reconstruction was obtained using the Operätt (C&S Healthcare 
Software AB, Mölndal, Sweden) software, which is the planning and 
database management application of the Dept. of Plastic Surgery´s 
operation theatres at Sahlgrenska University Hospital. The study 
period started from the year 2003, since that year Sahlgrenska began 
using electronic medical records that were easily accessible by the 
researchers. The end of 2009 was chosen as the end point, since from 
2010 onwards a prospective randomized study on the four most 
common methods of breast reconstruction has been running. 
In the next step, a FileMaker database (Filemaker Inc., Santa Clara, 
CA) was designed, which aimed to capture the entire reconstructive 
process from first referral to last follow-up visit. Numerous variables 
were collected for each patient (Table 1). A relatively large number of 
patients in the database had only undergone cosmetic corrections, 
reconstruction of the nipple/areola complex (NAC), or were lacking 
follow-up data for more than 30 days and were therefore excluded. 
Data on the parameters of interest was then extracted from the 
database. The inclusion and exclusion criteria were not identical 
between the studies; therefore, there is a difference in the number of 
patients in each study even if they come from the same pool. 
In Paper I, the study group was patients receiving first-time 
reconstruction with one of the 5 most common methods of delayed 
reconstruction used at the Department during the study time. This 
gave a total of 685 patients. 
As the method of DI was abandoned during the study period, it was 
decided for Paper II and III to omit this group and only use the more 
common methods of DIEP, LD, LTDF, and EXP. This gave a total of 
623 patients. 
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In the analysis of satisfaction and HR-QoL, it was decided not to 
exclude patients who had previously been reconstructed. Therefore, 
there are a total of 685 patients in Paper IV. That this number of 
patients is the same as in Paper I is purely coincidental. 
Patient data, from the first referral to last follow-up visit, were collected 
from the medical softwares Melior (Siemens Health Care, Upplands 
Väsby, Sweden) and Operätt. 
 
Table 1: Data collection for the database 
Signs of infection
Antibiotics administered
Bacterial culture taken
Complication of mammilla
Fat necrosis
Skin necrosis
Wound rupture
SF-36 Hematoma
Seroma
PGWB Pneumonia
Pneumothorax
Days of admittance Blood transfusion
Second operation DVT or lung embolus
Local of complication
Third operation Surgical treatment for complications
Implant event
Same factors as first operation
Date
(etc.)
Last follow-up visit
Yes / no
Included in study
Date of first operation
Drains
Implant (kind of implant)
Transexam acid adm.
Desmopressin adm.
Reoperation
Radiotherapy
Previous reconstruction
Breast reconstruction method
Follow-up time in months
EQ-5D
Breast-Q
Questionnaires
Implant replacement
Same factors as early follow-up
Dogears
Scar problems
PAD
Previous diseases
Duration of surgery
Operation codes
Antibiotic prophylaxis
Blood loss during surgery
Surgeon
Assistent 1
Assistent 2
Heredity for breast cancer
Bleeding disorder
Diabetes
Rheumatic disease
Lung disease
Heart disease
Renal disease
Liver disease
Direct reconstruction
Mastopexy
Late follow-up
DIEP flap
Latissimus dorsi flap
Lateral thoracodorsal flap
Expander / implant
Other
Date
Reoperation
First operation
Early follow up (< 30 days)
Hypothyroidism
Neurologic disease
DVT or lung embolus
Chemotherapy
Adjuvant hormone therapy
Corticosteroids
Direct implant
Other
Surgeon making assessment
Age
Smoking
BMI
Breast reduction
Breast augmentation
Breast cancer surgery
Contralateral breast
Length
Weight
Sector resection
Mastectomy
Name Date of first referral
Data collection
Social security number
Address
ASA
Anticoagulants
Pharmaceutical used
Surgeon making first assessment
ASA classification
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Data	extraction,	Paper	I	
Paper I was a retrospective single-centre study of patients with breast 
cancer who had undergone unilateral mastectomy and who were 
surgically treated with unilateral breast reconstruction procedures at 
the Department between 2003 and 2009. 
The inclusion criteria were first-time unilateral reconstruction with one 
of five different methods of delayed breast reconstruction: (1) DIEP, (2) 
LD, (3) LTDF, (4) EXP, and (5) DI; and the availability of data on at 
least 30 days of follow-up (Table 2). 
Exclusion criteria were data from a follow-up time of less than 30 days, 
if the patient was still under treatment or if only procedures other than 
first time reconstruction had been performed.  
Table 3 displays the data extraction for Paper I. 
Table 2: Inclusion and exclusion criteria, Paper I 
First	time	delayed	reconstruction	with: DIEP	flap
Latissimus	dorsi	flap
Lateral	thoracodorsal	flap
Expander	with	secondary	implant
Direct	implant
Data	from	follow	up	<	30	days
Inclusion	criteria:
Exclusion	criteria:
Table 3: Data extraction, Paper I 
Demography Main procedure
  Age 		Duration	of	surgery
  BMI 		Blood	loss	during	surgery
  Smoking 		Hospital	stay
  Chemotherapy 		Total	number	of	procedure
  Radiotherapy 		Total	duration	of	surgery
  Previous reconstruction 		Total	hospital	stay
  Pharmaceutical used Complications
  Concurrent diseases 		Early
  Follow-up time 		Late
Paper I 
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Reconstruction of the NAC was not specifically registered since not all 
patients requested this procedure. In the EXP group, the first and 
second procedures were compiled for all perioperative and follow-up 
parameters. Follow-up parameters and complications encountered 
were divided into early (≤30 days after surgery) and late (>30 days 
after surgery). Registered complications and definitions are displayed in 
Table 4. 
 
Data	extraction,	Papers	II	and	III	
As the method of DI was omitted for Paper II and III, the number of 
patients enrolled to the study was lower than that in Paper I. This also 
resulted in slightly different demographic variables for the overall group 
compared to Paper I; these variables were, of course, the same for each 
method group. 
Inclusion and exclusion criteria, registration of pharmaceuticals and 
concurrent diseases was the same as in Paper I. Definitions of 
complications were the same as in Paper I and follow-up parameters 
and complications encountered were registered in the same way. 
 Additionally, perioperative parameters registered were the name of 
the surgeon, duration of surgery (measured from the first incision to the 
last stitch) and blood loss during surgery (volume of blood in the 
suction system and the weight of gauzes used). 
 
Study	sample	and	data	extraction,	Paper	IV	
Table 5 displays the data extraction for Paper IV. The same demo-
graphical factors as for 
Papers I-III were 
collected. Registration of 
pharmaceuticals and 
concurrent diseases were 
the same as in Paper I. 
Only patients who 
responded to the HR- Table 5: Data extraction, Paper IV 
  Reconstruction method   Years from primary surgery
  Age   Follow-up time
  BMI 		ASA	Classification
  Smoking Complications
  Chemotherapy 		Early
  Radiotherapy 		Late
Paper IV
Demography
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QoL questionnaires were enrolled. Exclusion criteria were the same as 
in Paper I-III. 
Additionally, the number of years from primary reconstructive 
procedure to submitted questionnaires, follow up-time in months from 
first referral to last follow-up visit and scores of The American Society 
of Anaesthesiologists (ASA) physical status classification system were 
collected.195 
 
Statistics	
 
Statistics	of	Paper	I	
Patient and perioperative data were treated as independent variables. 
Statistical analyses were performed with SPSS (IBM, Armonk, NY) in 
all of the papers of this thesis. For the continuous scale parameters 
(BMI, follow-up times, blood loss during surgery, duration of surgery 
and hospital stay) the Kruskal-Wallis and Mann-Whitney U-tests were 
used. Age was tested with one-way ANOVA with a post-hoc LSD test. 
For statistics with dichotomous variables, logistic regression adjusted to 
the reconstruction method was used. For tests comparing all the 
different method groups together, p-values and area under the curve 
(AUC) values are presented. Results of comparisons between two 
groups are presented with odds ratio (OR), 95% confidence intervals 
(CI), and p-values. Any p-values less than 0.05 were considered 
statistically significant in all of the papers of this thesis. 
 
Statistics	of	Paper	II	and	III	
Logistic regression was used to study the association between the 
independent possible risk factors and the dependent outcome 
parameters (the postoperative complications). As the reconstruction 
methods varied significantly in terms of the duration of surgery, blood 
loss during surgery and the incidence of postoperative complications, 
all models were adjusted to the reconstructive method. This means that 
the reconstructive method itself was not a factor that could bias the 
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results of the statistical analysis. To establish whether the patient-
related factors, experience of the surgeon, the duration of the surgery 
or perioperative blood loss had an independent effect on the outcome 
factors, a multivariate logistic regression with adjustment for patient 
demographic parameters acting as confounding factors was performed. 
This means that all demographic factors that acted as confounding 
factors were statistically adjusted for and do not bias the results of the 
statistical analysis. Relationships between independent variables (i.e., 
possible risk factors) and dependent (outcome) variables are presented 
with OR, 95% CI and p-values. 
 
Statistics	of	Paper	IV	
The demographic factors and questionnaire answers were compared 
between the four surgical methods as independent variables. To 
evaluate the response rate and representativeness of the questionnaire’s 
responders, the four groups of surgical methods were also compared 
separately between responders and non-responders as independent 
variables. 
Normality of distribution was tested with Kolmogorov-Smirnov´s test. 
None of the demography variables and questionnaire answers were 
normally distributed. Accordingly, the Kruskal-Wallis test with post hoc 
pairwise comparisons and adjustment of significance levels was used. 
For dichotomous variables (history of smoking, chemotherapy, 
radiotherapy, early and late complications and need for re-surgery) the 
Chi square test was used. For response analysis the Mann-Whitney U 
test was used. 
Results of comparison between the groups are presented with median 
and minimum and maximum values. 
The results of the SF-36, EQ-5D and PGWB were analysed according 
to the instructions from their respective manuals and interpretation 
guides.185,196,197 Raw data from the Breast-Q questionnaire was 
transformed into a summary score for each scale, ranging from 0 to 
100, corresponding to “very dissatisfied” to “very satisfied,”193 using 
the Q-score software, which constructs scale scores from individual 
answers from each patient.194,198,199 
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4 RESULTS	
Summary	of	results,	Paper	I	
 
Demography	
A total of 685 patients undergoing first time reconstruction with DIEP, 
LD, LTDF, EXP or DI, and with existing data on at least 30 days of 
follow up were identified. The demographic results of Paper I are 
displayed in Table 6. 
 
Table 6: Summary of demographic parameters, pharmaceuticals, and concurrent diseases for the 
overall group and for each method 
All groups 
(N=685)
DIEP (n=104) LD   (n=113) LTDF (n=103) EXP (n=303) DI     (n=62) p-values
Follow up-time in months: mean ± SD 30.2 ± 19.5 31.2 ± 20.0 32.2 ± 19.1 31.0 ± 23.0 28.8 ± 18.8 30.5 ± 16.7 n.s.
Age in years: mean ± SD 56.4 ± 9.2 54.2 ± 7.2 55.3 ± 9.0 61.2 ± 8.1 55.7 ± 9.1 57.4 ± 11.6 <0.001
BMI: mean ± SD 25.2 ± 3.8 26.0 ± 3.3 25.1 ± 3.8 25.6 ± 4.8 24.8 ± 3.6 25.1 ± 4.1 0.009
Smoking 20.3% 16.0% 21.4% 24.4% 20.0% 20.8% n.s.
Chemotherapy 43.7% 66.7% 59.8% 36.7% 35.4% 26.7% <0.001
Radiotherapy 42.5% 82.7% 89.4% 30.5% 16.2% 31.1% <0.001
Pharmaceuticals 
Hormone therapy 55.3% 63.5% 60.2% 45.6% 56.4% 43.5% 0.024
Acetylsalicylic acid 4.7% 1.0% 2.7% 7.8% 5.3% 6.5% n.s.
Corticosteroids 0.7% 1.0% 1.8% 1.0% 0.0% 1.6% n.s.
Anticoagulants 0.7% 0.0 % 1.8% 1.0% 0.7% 0.0% n.s.
Concurrent diseases
Diabetes 2.9 % 1.9% 2.7% 4.9% 3.0% 1.6% n.s.
Hypothyroidism 11.1% 13.5% 13.3% 15.5% 8.6% 8.1% n.s.
Cardiovascual disease 3.9% 2.9% 1.8% 6.8% 4.6% 1.6% n.s.
History of thromboembolism 1.2% 1.0% 0,0% 3.9% 0.7% 1.6% n.s.
Coagulopathy 1.6% 0.0% 2.7% 1.0% 2.0% 1.6% n.s.
Rheumatic disease 5.4% 1.9% 6.2% 6.8% 5.3% 8.1% n.s.
Neurologic disease 1.9% 1.0% 3.5% 1.9% 2.0% 0.0% n.s.
Renal disease 1.8% 1.0% 1.8% 0.0% 2.6% 1.6% n.s.
Liver disease 1.0% 0.0 % 0.9% 2.9% 1.0% 0.0% n.s.
Lung disease 3.2% 1.9% 4.4% 4.9% 3.0% 1.6% n.s.
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Early	complications	
Early complications and differences between methods are presented in 
detail in Figure 9 and in Paper I. The DIEP group had the highest rate 
of early complications, including local complications such as fat 
necrosis, compared to all other groups. Postoperative antibiotics were 
administered more frequently in the DIEP group as a consequence of 
these local events; however, the signs of infection were not significantly 
more frequent in the DIEP group. Accordingly, the DIEP group had 
the most incidences of resurgery for complications. 
 
Early	overall	complications	
Early complications affected 30.5% of all patients. There were 
significant differences between the groups (p<0.001, AUC 0.620). The 
DIEP group had the highest rate at 50.0%, which was significantly 
higher than all other groups. 
 
Early	antibiotics	administered	
Early postoperative antibiotics were administered to 16.5% of all 
patients. There were significant differences between the groups 
(p=0.013, AUC 0.586). The DIEP group had the highest rate at 
27.9%, which was significantly higher than in the LD group (14.2%, 
p=0.014) and the EXP group (13.2%, p=0.001). 
 
Early	overall	local	complications	
Early local complications (fat necrosis, skin necrosis, wound rupture, 
hematoma and seroma accumulated) affected 16.8% of all patients. 
There were significant differences between the groups (p<0.001, AUC 
0.698). The DIEP group had the highest rate, at 35.6%, which was 
significantly higher than in the LD group (20.4%, p<0.013), the EXP 
group (7.3%, p<0.001) and the DI group (12.9%, p=0.002). 
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Figure 9: Early complication rates and reoperations (£30 days) for the five groups. Horizontal brackets show statistically significant differen                 
difference is given adjacent to the horizontal brackets 
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Early	surgery	for	complications	
There was surgical intervention due to early complications in 12.4% of 
all patients. There were significant differences between the groups 
(p<0.001, AUC 0.672). The DIEP group had the highest rate at 
26.9%, which was significantly higher than in the LD group (7.1%, 
p<0.001) and the EXP group (6.9%, p<0.001). 
 
Late	complications	
Late complications and differences between methods are presented in 
detail in Figure 10 and in Paper I. The pattern of late complications 
was considerably different from early complications. The DIEP and 
EXP groups had the lowest rate of both overall late complications and 
resurgery for complications and cosmetic corrections, while the other 
methods had a significantly higher rate. The LTDF and DI groups in 
particular had high rates of revision surgery. 
 
Late	overall	complications		
Late overall complications and need for surgical corrections affected 
54.7% of all patients. There were significant differences between the 
groups (p<0.001, AUC 0.625). The LTDF group had the highest rate 
at 74.8%, which was significantly higher than in the DIEP (46.2%, 
p<0.001) and the EXP (44.9%, p<0.001) groups. 
 
Late	overall	local	complications	
Late overall local complications (fat necrosis, skin necrosis, wound 
rupture, hematoma and seroma accumulated) affected 5.3% of all 
patients. There were significant differences between the groups 
(p=0.009, AUC 0.666). The DIEP group had the highest rate at 
11.5%, which was significantly higher than in the LD (3.5%, p=0.033), 
the EXP group (3.3%, p=0.041) and the DI groups (1.6%, p=0.049). 
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Secondary	corrective	surgery	
Late surgical intervention, due to complications or secondary cosmetic 
corrections, were performed in 49.5% of all patients. There were 
significant differences between the groups (p<0.001, AUC 0.617). The 
LTDF group had the highest rate at 67.0%, which was significantly 
higher than in the EXP (39.9%, p<0.001) and the DIEP groups 
(40.4%, p<0.001). 
 
Implant	related	complications	
Implant related complications are presented in Table 7. In summary, 
the frequency of implant extraction and implant rupture is generally 
low, as is capsular contraction. This is considering that a relatively 
large number of the patients had a history of radiotherapy. 
Implant-related complications affected 29.6% of all patients with an 
implant-based reconstruction. There were significant differences 
between the groups (p=0.014, AUC 0.580). Intergroup comparison 
showed that the DI group had the highest rates of implant related 
events at 37.1%, which was significantly higher than the EXP group 
(24.1%, p=0.036). The LTDF group (39.6%) had a significantly higher 
rate than the EXP group (p=0.004). In the LD group, 32.4% of the 
patients were affected. 
More detailed results of the intergroup comparison (OR and 95% CI), 
are found in Paper I. 
 
 
Table 7: Summary of all implant-related events for the groups with implant-based reconstructions, 
both in numbers and percentage 
Total implant related event 166 28.6% 34 30.1% 36 35.0% 73 24.1% 23 37.1%
   N extraction of implant (%) 20 3.4% 2 1.8% 5 4.9% 6 2.0% 7 11.3%
   N capsular contraction (%) 124 21.3% 27 23.9% 27 26.2% 54 17.8% 16 25.8%
   N wound rupture with implant exposure (%) 12 2.1% 2 1.8% 4 3.9% 5 1.7% 1 1.6%
   N diagnosed implant rupture (%) 2 0.3% 1 0.9% 0 0.0% 1 0.3% 0 0.0%%
   N implant dislocation (%) 9 1.5% 2 1.8% 0 0.0% 7 2.3% 0 0.0%%
All groups 
(N=581)
Latissimus 
dorsi (n=113)
Thoracodorsal 
flap (n=103)
Expander / 
implant (n=303)
Direct implant 
(n=62)
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Summary	of	results,	Paper	II	and	III	
 
A total of 623 patients undergoing reconstruction with DIEP, LD, 
LTDF or EXP and existing data on at least 30 days of follow up were 
identified. The demographic parameters are displayed in Table 8. 
 
	
	
Blood	loss	as	an	independent	risk	factor	for	complications	
	
Table 9 shows the association between the amount of blood loss and 
the risks for postoperative complications. The univariate model shows 
an association between increased blood loss in 10-ml increments and 
increased risk for numerous early and late complications. The 
multivariate model, adjusted for the reconstructive method and for all 
demographic factors acting as confounding factors, shows that for each 
10-ml of blood loss during the procedure, the risk for overall early 
complications (OR 1.019, p=0.017), early seroma (OR 1.016, 
p=0.037), early resurgery for complications (OR 1.019, p=0.010), late 
overall complications (OR 1.019, p=0.024) and late fat 
Table 8: Demography, overall group and each method, Paper II and III 
Demography Overall (n=623)
DIEP     
(n=104)
LD         
(n=113)
LTDF     
(n=103)
Follow up time (months ± SD) 30.2 ± 19.5 31.2 ± 20.0 32.2 ± 19.1 31.0 ± 23.0
Age (years ± SD) 56.3 ± 8.9 54.2 ± 7.2 55.3 ± 9.0 61.2 ± 8.1
Age (range) 31-83 37-71 31-76 43-80
BMI (mean ± SD) 26.0 ± 3.3 25.1 ± 3.8 25.6 ± 4.8 24.8 ± 3.6
BMI (range) 17.7-38.7 19.3-35.1 18.4-34.6 18.5-37.6
Smoking 20.2% 16.0% 21.4% 24.4%
Previous chemotherapy 45.4%% 66.7% 59.8% 36.7%
Previous radiotherapy 43.6%% 82.7% 89.4% 30.5%
Hormone therapy 56.5%% 63.5% 60.2% 45.6%
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necrosis (OR 1.023, p=0.031) all increased. Thus, for example, the risk 
for encountering any early complication increased by 1.9% for each 
10-ml of blood loss during the surgical procedure (Figure 11). As a 
result, significant blood loss during a procedure can explain why there 
is a substantial increase in the risk for an early overall complication. 
 
Table 9: Blood loss as an independent risk factor for complications 
Odds ratio (95 % CI) p-value Odds ratio (95 % CI) p-value
  Overall complications (n=192) 1.022 (1.013-1.030) <0.001 1.019 (1.003-1.036) 0.017
  Signs of infection (n=80) 1.008 (1.000-1.016) 0.040 1.008 (0.997-1.019) 0.157
  Antibiotics administration (n=104) 1.008 (1.000-1.016) 0.040 1.004 (0.995-1.014) 0.374
  Local overall complications (n=107) 1.010 (1.002-1.018) 0.018 1.002 (0.992-1.012) 0.715
  Fat necrosis (n=26) 1.025 (1.012-1.038) <0.001 1.013 (0.997-1.029) 0.125
  Skin necrosis (n=41) 1.010 (1.001-1.018) 0.032 1.004 (0.991-1.017) 0.565
  Hematoma (n=26) 1.005 (0.996-1.015) 0.277 1.007 (0.988-1.026) 0.484
  Seroma (n=40) 1.010 (1.001-1.020) 0.024 1.016 (1.001-1.032) 0.037
  Wound rupture (n=9) 1.007 (0.994-1.020) 0.302 n.a.**
  Resurgery for complications(n=76) 1.023 (1.014-1.033) <0.001 1.019 (1.001-1.037) 0.039
  Overall complications (n=336) 1.002 (0.995-1.008) 0.567 1.006 (0.995-1.016) 0.320
  Signs of infection (n=57) 1.006 (0.998-1.014) 0.115 1.004 (0.993-1.015) 0.473
  Antibiotics administration (n=63) 1.005 (0.997-1.013) 0.213 1.004 (0.993-1.015) 0.502
  Local overall complications (n=35) 1.016 (1.004-1.027) 0.007 1.019 (1.003-1.036) 0.024
  Fat necrosis (n=19) 1.018 (1.004-1.031) 0.011 1.023 (1.002-1.044) 0.031
  Skin necrosis (n=8) 1.007 (0.994-1.020) 0.306 n.a.**
  Hematoma (n=2) 0.994 (0.898-1.100) 0.905 n.a.**
  Wound rupture (n=9) 1.006 (0.991-1.021) 0.434 n.a.**
  Seroma (n=4) 0.993 (0.944-1.046) 0.802 n.a.**
  Scar problems (n=24) 1.005 (0.995-1.015) 0.339 0.982 (0.949-1.017) 0.305
  Dogears (n=49) 1.002 (0.992-1.012) 0.729 1.001 (0.988-1.015) 0.839
  Resurgery/Cosmetic corrections (n=301) 1.001 (0.995-1.007) 0.793 1.006 (0.996-1.017) 0.251
*age, BMI, smoking, diabetes, corticosteroids, adjuvant hormonal therapy, chemotherapy, radiotherapy and 
reconstruction method
**Due to low occurrance frequency, early wound rupture, late skin necrosis, late hematoma,  late wound 
rupture and late seroma were not applicable for multivariate analysis.
Late complications
Blood loss                         
(10-ml steps)
Univariate models Adjusted for confounding factors*
Early complications
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Duration	of	surgery	as	an	independent	risk	factor	
for	complications	
Table 10 shows the association between the duration of surgery and 
the risks for postoperative complications. The univariate model shows 
a clear association between increased duration of surgery in 10-minute 
increments and increased risk for numerous early and late 
complications. The multivariate model, adjusted for the reconstructive 
method and all demographic factors acting as confounding factors, 
shows that for each 10-minute increase in duration of surgery, the risk 
for overall early complications increased (OR 1.052, p=0.019). Thus, 
the risk for encountering any early complication increased by 5.2% for 
each 10 minute increase in the duration of surgery (Figure 12). As a 
result, a long duration of surgery can explain a substantial increase of 
the risk for any early complication. 
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Figure 11: Risk model, perioperative blood loss, early complications 
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Table 10: Duration of surgery as an independent risk factor for complications 
Odds ratio (95 % CI) p-value Odds ratio (95 % CI) p-value
  Overall complications (n=192) 1.040 (1.026-1.056) <0.001 1.052 (1.008-1.097) 0.019
  Signs of infection (n=80) 1.020 (1.002-1.038) 0.027 1.050 (0.990-1.114) 0.107
  Antibiotics administration (n=104) 1.030 (1.014-1.047) <0.001 1.019 (0.967-1.074) 0.477
  Local overall complications (n=107) 1.042 (1.026-1.059) <0.001 1.018 (0.967-1.071) 0.504
  Fat necrosis (n=26) 1.085 (1.057-1.114) <0.001 1.038 (0.962-1.121) 0.338
  Skin necrosis (n=41) 1.059 (1.037-1.081) <0.001 1.048 (0.982-1.117) 0.156
  Hematoma (n=26) 1.011 (0.981-1.042) 0.483 0.913 (0.814-1.025) 0.125
  Seroma (n=40) 1.014 (0.990-1.039) 0.252 1.049 (0.954-1.152) 0.324
  Wound rupture (n=9) 1.035 (0.993-1.078) 0.102 n.a.**
  Resurgery for complications(n=76) 1.041 (1.024-1.059) <0.001 1.008 (0.954-1.066) 0.771
  Overall complications (n=336) 0.994 (0.981-1.007) 0.357 0.994 (0.952-1.039) 0.799
  Signs of infection (n=57) 1.012 (0.991-1.033) 0.269 1.026 (0.958-1.099) 0.463
  Antibiotics administration (n=63) 1.014 (0.994-1.034) 0.173 1.036 (0.968-1.109) 0.304
  Local overall complications (n=35) 1.036 (1.013-1.059) 0.002 1.008 (0.937-1.085) 0.823
  Fat necrosis (n=19) 1.043 (1.014-1.073) 0.003 1.015 (0.928-1.111) 0.742
  Skin necrosis (n=8) 1.053 (1.012-1.095) 0.010 n.a.**
  Hematoma (n=2) 0.733 (0.463-1.162) 0.187 n.a.**
  Wound rupture (n=9) 0.971 (0.868-1.085) 0.601 n.a.**
  Seroma (n=4) 1.007 (0.955.1.060) 0.808 n.a.**
  Scar problems (n=24) 1.035 (1.008-1.064) 0.012 1.009 (0.928-1.098) 0.830
  Dogears (n=49) 1.003 (0.978-1.027) 0.839 1.054 (0.972-1.142) 0.203
  Resurgery/Cosmetic corrections (n=301) 0.992 (0.978-1.005) 0.219 0.985 (0.943-1.030) 0.513
*age, BMI, smoking, diabetes, glucocorticoids, adjuvant hormonal therapy, chemotherapy, radiotherapy
and reconstruction method
**Due to low occurrance frequency, early wound rupture, late hematoma, late skin necrosis,  late wound 
rupture and late seroma were not applicable for multivariate analysis.
Duration of surgery                       
(10-min steps)
Univariate models
Adjusted for confounding 
factors*
Early complications
Late complications
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Patient-related	factors	as	independent	risk	
factors	for	complications	
 
 
Early	complications	
Table 11 displays in detail the statistically significant associations 
between the patient-related factors and early complications. In the 
multivariate model, the patient factor related to highest number of 
early complications was smoking, with increased BMI and a history of 
radiotherapy coming in second and third, respectively. Age seemed to 
be a protective factor against the development of early seroma. 
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Figure 12: Risk model, duration of surgery, and early overall complications 
Breast reconstructive surgery: Risk factors for complications and health-related quality of life 
 
52 
 
 
Table 11: Statistically significant associations between patient-related factors and early 
complications. Univariate and multivariate models. n.s.=non-significant 
OR (95 % CI) p-value OR (95 % CI) p-value
BMI 1.08  (1.03-1.14) 0.002 1.07  (1.01-1.13) 0.017
Smoking 1.65  (1.07-2.54) 0.023 2.05  (1.25-3.37) 0.005
Radiotherapy 1.87  (1.32-2.65) <0.001 n.s. n.s.
BMI 1.08  (1.01-1.16) 0.018 n.s. n.s.
BMI 1.13  (1.06-1.20) <0.001 1.10  (1.04-1.18) 0.002
Smoking 1.84  (1.11-3.03) 0.017 2.10  (1.19-3.71) 0.010
Hormone therapy 1.56  (1.01-2.43) 0.046 n.s. n.s.
Radiotherapy 1.77  (1.15-2.73) 0.009 2.03  (1.24-3.30) 0.005
Smoking 2.28  (1.40-3.72) 0.001 2.77  (1.61-4.75) <0.001
Radiotherapy 3.20  (2.04-5.01) <0.001 2.03  (1.09-3.75) 0.025
Smoking 2.70  (1.36-5.33) 0.004 3.64  (1.67-7.93) 0.001
Radiotherapy 3.13  (1.55 - 6.30) 0.001 n.s. n.s.
BMI 1.22  (1.10-1.36) <0.001 n.s. n.s.
Smoking 3.00  (1.29-6.95) 0.010 n.s. n.s.
Radiotherapy 7.29  (2.47-21.51) <0.001 n.s. n.s.
Smoking 3.52  (1.48-8.36) 0.004 n.s. n.s.
Age 0.96  (0.93-1.00) 0.030 0.95  (0.92-0.99) 0.016
Radiotherapy 2.18  (1.12-4.24) 0.022 n.s. n.s.
BMI 1.11  (1.04-1.19) 0.003 1.09  (1.01-1.17) 0.029
Radiotherapy 1.73  (1.05-2.83) 0.031 n.s. n.s.
Univariate model
Early overall complications
Early resurgery
Early seroma
Early hematoma
Early fat necrosis
Early skin necrosis
Early overall local complications
Early administration of antibiotics
Early signs of infection
Multivariate model
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Independent	risk	factors	combined	
BMI (OR 1.07, p=0.017) and smoking (OR 2.05, p=0.005) were 
independent patient-related risk factors for overall early complications. 
Thus, the risk for encountering overall early complications rose by 7% 
for each unit of BMI increase, and the risk increased over 200% if the 
patient was a smoker. When both risk factors were combined, the 
mean predicted probability was 230% higher for smokers with a BMI 
of 30 compared to non-smokers with a BMI of 20. The patients in the 
expander group had the greatest increase at 3.8-fold for the 
combination of high BMI and being a smoker (Figure 13). 
Smoking (OR 2.77, p<0.0001) and radiotherapy (OR 2.03, p=0.025) 
were independent patient-related risk factors for early local 
complications. Thus, the risk for encountering early local 
complications rose by 277% if the patient was a smoker, and the risk 
increased by over 200% if the patient had been irradiated. The 
predicted probability for all methods increased a mean 3.6-fold for 
smokers who had undergone radiotherapy compared to patients who 
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Figure 13: Smoking and BMI combined as risk factors for early overall complications 
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were neither smokers nor had undergone radiotherapy. The patients in 
the expander group had the greatest increase of 4.6-fold for the 
combination of smoking and radiotherapy (Figure 14). 
When BMI (OR 1.10, p=0.002) was added as a third risk factor to 
smoking and radiotherapy, the association with early administration of 
antibiotics rose manifold. A smoking, irradiated patient with a BMI of 
30 had a 7.2-fold risk for early administration of antibiotics than a non-
smoking, non-irradiated patient with a BMI of 20 (Figure 15). 
Hypothyroidism, cardiovascular disease, coagulopathy, renal disease, 
liver disease and lung disease had no statistically significant relationship 
to any of the complications registered. 
 
 
 
Figure 14: Smoking and radiotherapy combined as risk factors for early local 
complications 
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Late	complications		
Table 12 displays in detail the associations between the statistically 
significant patient-related factors and late complications. In the 
multivariate model, the patient factors related to the highest number of 
the subgroups of late complications were high BMI (late overall 
complications, late signs of infection, late administration of antibiotics 
and late fat necrosis) and history of radiotherapy (late overall 
complications, late administration of antibiotics, late overall local 
complications and late fat necrosis). Smoking was only associated with 
late resurgery. 
Figure 15: BMI, smoking and radiotherapy combined as risk factors for early administration of 
antibiotics, all groups combined 
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Table 12: Statistically significant associations between patient-related factors and late 
complications. Univariate and multivariate models. n.s.=non-significant 
OR (95 % CI) p-value OR (95 % CI) p -value
BMI 1.06  (1.01-1.12) 0.014 1.06  (1.00-1.11) 0.042
Rheumatic disease 2.27  (1.03-4.99) 0.041 n.s. n.s.
Radiotherapy 1.79  (1.29-2.49) <0.0001 1.66  (1.01-2.74) 0.046
BMI 1.19  (1.10-1.28) <0.0001 1.18  (1.09-1.28) <0.001
BMI 1.13  (1.05-1.21) 0.001 1.11  (1.03-1.20) 0.007
Acetylsalicylic acid 3.93  (1.65-9.33) 0.002 6.08  (2.29-16.11) <0.001
Radiotherapy 1.72 (1.01-2.93) 0.046 1.89  (1.04-3.42) 0.037
Metabolic disease 2.47  (1.08-5.67) 0.033 n.s. n.s.
Radiotherapy 3.31  (1.56-7.06) 0.002 3.79  (1.54-9.33) 0.004
Radiotherapy 9.27  (1.13-75.82) 0.038 n.s. n.s.
BMI 1.20  (1.08-1.35) 0.001 1.18  (1.05-1.33) 0.005
Radiotherapy 3.48  (1.23-9.90) 0.019 3.37  (1.17-9.70) 0.024
Age (years) 1.21  (1.00-1.46) 0.046 n.s. n.s.
Diabetes 33.5  (2.01-557.09) 0.014 n.s. n.s.
Metabolic disease 7.97  (1.11-57.50) 0.039 n.s. n.s.
Age 1.13  (1.026-1.21) 0.009 n.s. n.s.
Radiotherapy 9.27  (1.13-75.82) 0.038 n.s. n.s.
Smoking 1.92  (1.25-2.94) 0.003 1.88  (1.21-2.92) 0.005
Reumatic disease 2.46  (1.15-5.29) 0.021 2.44  (1.07-5.57) 0.033
Radiotherapy 1.55  (1.12-2.14) 0.008 n.s. n.s.
Multivariate modelUnivariate model
Late overall complications
Late resurgery
Late wound rupture
Late seroma
Late hematoma
Late fat necrosis
Late skin necrosis
Late overall local complications
Late administration of antibiotics
Late signs of infection
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Independent	risk	factors	combined	
BMI (OR 1.06, p=0.042) and a history of radiotherapy (OR 1.66, 
p=0.046) were independent patient-related risk factors for late overall 
complications. Thus, the risk of encountering overall late complications 
rose by 6% for each unit of BMI increase, and the risk rose by 66% if 
the patient was irradiated. When both risk factors were combined, an 
irradiated patient with a BMI of 30 had a 2.3-fold higher risk for late 
overall complications compared with a non-irradiated patient with a 
BMI of 20 (Figure 16). 
 
 
The patient-related factors of smoking (OR 1.88, p=0.005) and 
rheumatic disease (OR 2.44, p=0.033) were independent risk factors 
for late resurgery. Thus, the risk for encountering late resurgery was 
88% higher if the patient was a smoker, and 244% higher if the patient 
had rheumatic disease. A smoking patient with a history of rheumatic 
disease had an over 3-fold higher risk for late resurgery compared to 
that in a non-smoking patient without rheumatic disease (Figure 17). 
Figure 16: Radiotherapy and BMI as risk factors for late overall 
complications 
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BMI (OR 1.18, p=0.005), and radiotherapy (OR 3.37, p=0.024) were 
independent patient-related risk factors for late fat necrosis. Thus, the 
risk for encountering late fat necrosis rose by 18% for each unit of 
increased BMI, and the risk increased by 337% if the patient was 
irradiated. An irradiated patient with a BMI of 30 had a 16.4-fold 
higher risk for late fat necrosis than a non-irradiated patient with BMI 
of 20 (Figure 18). 
 
 
 	
Figure 17: Smoking and rheumatic disease combined as risk factors for late resurgery 
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Summary	of	results,	Paper	IV	
 
Patient	selection	and	demography	
Figure 19 shows the patient selection for the study of Paper IV. A total 
of 685 patients undergoing reconstruction with DIEP, LD, LTDF or 
EXP and having existing data on at least 30 days of follow up were 
identified. Three hundred forty one patients were excluded according 
to the exclusion criteria. A total of 459 patients responded to the 
questionnaires (67.0%) with no significant differences between the 
groups (p=0.338). 
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Figure 18: BMI and radiotherapy combined for late fat necrosis 
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Table 13 displays demographic data for the overall group and for each 
method of reconstruction. There were significant differences between 
the groups regarding BMI, age at the time of surgery, follow-up time, 
years since primary surgery to submission of questionnaire answers, 
chemotherapy and radiotherapy. 
	
 
	
	
	
Figure 19: Patient selection and rates of response to HR-QoL questionnaires divided 
into method groups 
Overall group
n=685
Responders
n=459 (67.0%)
DIEP 
n=69 (62.7%)
LD
n=76 (68.5%)
LDTF 
n=61 (64.2%)
EXP
n=253 (68.6%)
Non-
responders
n= 226 (33.0%)
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Results	of	SF-36:	
Comparison	between	
study	groups	
The detailed results of SF-36 results 
and comparison between the four 
method groups are displayed in 
Figure 20. There were significant 
differences between groups in the 
vitality domain, where patients in 
the DIEP group had a lower score 
than the LTDF (p=0.019) and EXP 
(p=0.022) groups. 
 
 
Results	of	SF-36:	Overall	
group	compared	to	
normal	population	
Figure 21 displays the results from 
the comparison between the overall 
study group (all methods) and 930 
age-matched women from the 
Swedish general population. 
Patients in the study group had a 
significantly higher score in the 
domain of physical functioning 
(p<0.001). The age- matched 
normal population had higher 
scores in the domains of general 
health (p<0.001), vitality (p<0.001), 
social functioning (p=0.013), mental 
health (p<0.001) and the mental 
component summary (p<0.001). 
 
Ta
bl
e 1
3:
 D
em
og
ra
ph
y, 
Pa
pe
r I
V.
 S
tat
ist
ica
lly
 si
gn
ifi
ca
nt
 re
su
lts
 a
re 
in
 re
d 
De
m
og
ra
ph
y
Ov
er
al
l (
n=
68
5)
DI
EP
 (n
=1
10
)
LD
 (n
=1
11
)
LT
DF
 (n
=9
5)
Ex
p 
(n
=3
69
)
Si
gn
.
BM
I: m
ed
ia
n 
(m
in
 - 
m
ax
) 
24
.6
 (1
9.
0-
40
.2
)
25
.9
 (1
9.
3-
35
.1
)
25
.3
 (1
9.
5-
34
.6
)
25
.9
 (1
9.
0-
40
.2
)
24
.0
 (1
9.
3-
37
.0
) 
p 
= 
0.
00
1
Ag
e 
at
 ti
m
e 
of
 su
rg
er
y: 
m
ed
ia
n 
(m
in
-m
ax
)
58
 (2
9-
83
)
54
 (3
9-
71
)
57
 (3
4-
76
)
62
 (4
6-
78
)
58
 ( 
29
-8
3)
p 
< 
0.
00
1
Fo
llo
w
-u
p 
tim
e 
in
 m
on
th
s: 
m
ed
ia
n 
(m
in
 - 
m
ax
)
28
.2
 (0
-1
07
)
25
.8
 (0
-7
9)
25
.4
 (6
-9
9)
25
.9
 (0
-9
8)
32
.1
 (4
-1
07
)
p 
= 
0.
03
2
Ye
ar
s s
in
ce
 p
rim
ar
y o
p 
to
 q
ue
st
io
nn
ai
re
: m
ed
ia
n 
(m
in
 - 
m
ax
)
5 
(0
-9
)
5.
5 
(0
-8
)
5 
(0
-9
)
6 
(0
-8
)
5 
(0
-9
)
p 
< 
0.
00
1
AS
A:
 m
ed
ia
n 
(m
in
 - 
m
ax
)
1 
(1
-3
)
1 
(1
-2
)
1 
(1
-3
)
1 
(1
-2
)
1 
(1
-2
) 
p 
= 
0.
51
9
Sm
ok
in
g:
 n
/n
 o
f k
no
w
n 
(%
)
21
.3
%
15
.3
%
26
.5
%
23
.0
%
21
.0
%
p 
= 
0.
27
5
Ch
em
ot
he
ra
py
: n
/n
 o
f k
no
w
n 
(%
)
43
.4
%
66
.7
%
57
.3
%
34
.8
%
34
.2
%
p 
< 
0.
00
1
Ra
di
ot
he
ra
py
: n
/n
 o
f k
no
w
n 
(%
)
40
.9
%
66
.7
%
88
.3
%
19
.8
%
17
.6
%
p 
< 
0.
00
1
Breast reconstructive surgery: Risk factors for complications and health-related quality of life 
 
62 
 
  
    
40
 
50
 
60
 
70
 
80
 
90
 
10
0 
 
 
 
 
 
 
   
   
 
 
 
 
   
 
   
   
  
 
 
  
 
  
D
IE
P 
LD
 
LT
D
F 
EX
P 
0           
Ph
ys
ic
al
 
fu
nc
tio
ni
ng
 
Ro
le
 p
hy
si
ca
l 
Bo
di
ly
 p
ai
n 
G
en
er
al
   
   
he
al
th
 
Vi
ta
lit
y 
So
ci
al
 
fu
nc
tio
ni
ng
 
Ro
le
   
em
ot
io
na
l 
M
en
ta
l  
   
   
he
al
th
 
Ph
ys
ic
al
 
co
m
po
ne
nt
 
su
m
m
ar
y 
M
en
ta
l 
co
m
po
ne
nt
 
su
m
m
ar
y  
 
  
p=
0.
01
9'
p=
0.
02
2'
Fi
gu
re 
20
: S
F-
36
 - 
Co
mp
ar
iso
n 
be
tw
een
 re
co
ns
tru
cti
on
 m
eth
od
s 
Andri Thorarinsson, MD 
 
63 
 
 
		
 	
    
40
 
50
 
60
 
70
 
80
 
90
 
10
0 
 
 
 
 
 
 
   
  
 
 
 
 
 
 
   
  
 
 
  
 
  
St
u
d
y 
g
ro
u
p
 
N
o
rm
al
 p
o
p
u
la
ti
o
n
 
0           
Ph
ys
ic
al
 
fu
n
ct
io
n
in
g
 
Ro
le
 p
hy
si
ca
l 
Bo
d
ily
 p
ai
n
 
G
en
er
al
   
  
h
ea
lt
h
 
Vi
ta
lit
y 
So
ci
al
 
fu
n
ct
io
n
in
g
 
Ro
le
 e
m
o
ti
o
n
al
 
M
en
ta
l  
   
h
ea
lt
h
 
Ph
ys
ic
al
 
co
m
p
o
n
en
t 
su
m
m
ar
y 
M
en
ta
l 
co
m
p
o
n
en
t 
su
m
m
ar
y 
 
 
 
 
p
<
0.
00
1 
p
<
0.
00
1 
p
<
0.
00
1 
p
=
0.
01
3 
p
<
0.
00
1 
p
<
0.
00
1 
Fi
gu
re 
21
: S
F-
36
 co
mp
ar
iso
n 
be
tw
een
 ov
era
ll 
gro
up
 (a
ll 
me
tho
ds
) a
nd
 9
30
 ag
e m
atc
he
d v
alu
es 
fro
m 
no
rm
al
 p
op
ul
ati
on
 
Breast reconstructive surgery: Risk factors for complications and health-related quality of life 
 
64 
 
Results	of	SF-36:	Each	group	
When each subgroup of the four reconstruction methods was 
compared with the general population, all methods had significantly 
lower scores in the domains of general health, vitality, mental health and the 
mental component summary (all p-values <0.001).  
The DIEP group had a significantly higher score in the domain of 
physical functioning (p<0.041) than the general population. The 
difference was not statistically significant among the other three 
groups. 
 
EQ-5D	–	comparison	between	groups	
There were no significant differences between the subgroups of the 
four reconstruction methods, neither among the descriptive items nor 
the VAS scale. 
	
PGWB	–	comparison	between	groups	
There were no significant differences in the global score between the 
subgroups of the four reconstruction methods. There were also no 
significant differences between the subgroups in each of the domains of 
anxiety, depressed mood, positive well-being, self-control, general health and 
vitality. 
 
Breast-Q,	comparison	between	study	groups	
The detailed results of the comparison between the reconstruction 
method groups are displayed in Figure 22. There were significant 
differences between the groups regarding the Breast-Q scale of 
satisfaction with breasts (p<0.001); the DIEP group had a higher score 
compared to the other groups. Regarding the scale of satisfaction with 
outcome, the DIEP group also had a higher score compared with that of 
the LTDF and EXP groups. 
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Figure 22: Breast-Q comparison between the reconstruction methods. P-values under the domain of satisfaction with breasts and satisfaction with 
together. Horizontal brackets show statistically significant differences between groups, where the colour indicates the group with higher value. The p-valu           
brackets 
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There was a trend for the DIEP group to have a higher score than the 
other groups in the domains of psychosocial well-being, sexual well-being, 
physical well-being chest and satisfaction with information, medical staff and office 
staff, but the difference did not reach statistical significance. 
 
Response	analysis	
Table 14 shows the demographic parameters for all groups, separated 
into responders and non-responders. There were no significant 
differences in the overall group between responders and non-
responders regarding BMI, ASA classification, history of radiotherapy, 
early complication rate and early and late re-surgery. There were 
significant differences in age at time of surgery showing the responders 
were older than the non-responders (p=0.001). The follow-up time was 
shorter in the responders group than the non-responders group 
(p=0.009). The non-responder group had higher frequencies of 
smoking (p<0.001) and more frequent history of chemotherapy 
(p=0.004). Additionally, the responders had a higher late complication 
rate (p=0.045). 
 
  
All groups Respondents 
(n=419)
Non-respondents 
(n=266)
p-value
BMI: median (min - max) 24.8 (18.2 - 40.2) 24.4 (17.7 - 37.0) 0.368
Age at time of surgery: median (min - max) 58 (29 - 77) 55 (31 - 83) 0.001
Follow up time in months: median (min - max) 28.0 (0 - 107) 30.9 (0 - 106) 0.009
ASA: median (min-max) 1 (1 - 3) 1 (1 - 2) 0.528
Smoking: n/n of known* (%) 75/510 (14.7%) 53/167 (31.7%) <0.001
Chemotherapy: n/n of known* (%) 186/480 (38.8%) 104/206 (50.7%) 0.004
Radiotherapy: n/n of known* (%) 172/476 (36.1%) 91/209 (43.5%) 0.067
Early complications rate 126/419 (30.1%) 95/266 (35.71%) 0.124
Early resurgery rate 21/419 (5.0%) 23/266 (8.6%) 0.059
Late complications rate 154/419 (36.8%) 78/266 (29.3%) 0.045
Late resurgery rate 54/419 (12.9%) 34/266 (12.8%) 0.968
Table 14: Response analysis. Comparison between responders and non-responders. Significant 
differences are in red 
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5 DISCUSSION	
 
General	issues	
Breast cancer comprises 22.9% of all invasive cancers in women 
making it the most common invasive cancer.1,2 The incidence is 
increasing, affecting increasingly younger women. Mortality in 
developing countries is also increasing, although, in western Europe 
and the US, survival is maintained or is slightly increasing.8 
In Sweden, the incidence of breast cancer has more than doubled since 
the National Board of Health and Welfare’s Cancer Registry started in 
the fifties,11 resulting in an increasing number of breast cancer 
survivors. Breast reconstruction after mastectomy is therefore 
becoming more frequent.13,14 About 40% of women in Gothenburg, 
who have undergone mastectomy due to breast cancer request breast 
reconstruction.17 
Surgery is still the primary treatment for breast cancer, but adjuvant 
therapy is frequently used to improve survival rates, with radiotherapy, 
chemotherapy, and hormone therapy being the most common.200 
A third of women treated with mastectomy experience persistent 
psychosocial morbidity, with reduced self-esteem, insomnia, increased 
anxiety, depression, disturbed body image, and/or sexual problems.18-
21 Both primary and secondary breast reconstruction, after 
mastectomy, have been shown to enhance self-esteem and quality of 
life compared to the absence of any reconstruction.22-25 
The principal aim of breast reconstruction is to reverse the deformity 
created by mastectomy.201 However, even if this is accomplished, the 
larger aim should be to normalize the body image, the HR-QoL, and 
to satisfy patients with the results of the reconstruction. Consequently, 
the patient’s expectations are always the key to a successful breast 
reconstruction. 
Many methods for breast reconstruction have been introduced, and all 
have their advantages and disadvantages. Implant-based 
reconstructions are generally seen as fast and reliable, but they have a 
distinct range of complications (especially late complications), while 
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autologous reconstructions are more expensive, but have the obvious 
advantage of only using the patients´ own tissue. The method of choice 
depends on anatomical factors, concurrent morbidity, requests of the 
patient, and the preferences of the surgeon. Many reports provide 
descriptions and recommendations for different reconstructive 
methods.26,27,202-206 However, no consensus or generally accepted 
guidelines exist on the method of choice for each individual patient. 
Most studies in the plastic surgery literature evaluate only a single 
method or compare two different methods.54-58,71,76,103,107,207,208 
Complications after breast reconstruction are common, and many 
patients are exposed to avoidable complications.53-58,209 Several studies 
have suggested that complications significantly affect patient 
satisfaction and emotional well-being.57,63,64,210,211 
For a complete understanding of the methods for breast reconstruction, 
the research has to include: 
 Clear description of the method, including all surgical steps to 
achieve reproducible results 
 The definitions and evaluations of both medical and surgical 
postoperative complications 
 Evaluation of aesthetic results and patient satisfaction 
 Health-related economics; how different methods provide a 
health-related benefit regarding long-term cost  
 The outcome in terms of HR-QoL, with the use of generally 
accepted HR-QoL instruments and questionnaires 
 
The present thesis meets several of these requirements. Firstly, the 
approach to each of the four reconstructive methods has been 
comprehensively described26-29 and all surgeons at the department 
have had thorough training in all of the methods, except the operations 
involving microsurgery. Secondly, the analysis of all complications with 
the same definitions is carried out in Paper I. Thirdly, the 
measurements of changes in HR-QoL have been carried out by 
applying both generic (SF-36, EQ-5D, and PGWB) and specific (the 
Breast-Q) questionnaires, commonly used to measure HR-QoL. The 
SF-36 is one of the most frequently used instruments for assessing 
general health, and is designed for a large population of patients. 167 
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Breast-Q is widely used in measuring the effect of breast reconstruction 
on satisfaction and HR-QoL.194 In SF-36, the results are compared 
with age-matched data from the Swedish general population. 
Unfortunately, preoperative data could not be obtained before the start 
of these studies, so comparisons before and after surgery could not be 
made. Additionally, assessments of aesthetic results have not been 
carried out in the present thesis. There have been many attempts at 
assessing aesthetic results by using photographs,212-215 but so far there is 
no general agreement on the methodology, and the published studies 
are based on weak scientific data. The only measurements on aesthetic 
results in this thesis are indirect measurements collected using the 
Breast-Q’s domains, which include satisfaction with breasts and satisfaction 
with overall outcome, where only the patient does the assessment. 
Additionally, there is no attempt made to estimate the cost of each of 
the methods studied. That aspect was considered as out of the scope of 
this thesis. 
Accordingly, the aim of the present thesis was to examine the 
frequency of complications, to find independent risk factors for 
complications among perioperative and patient-related factors, and to 
examine differences in HR-QoL between women having undergone 
breast reconstruction and the general population, as well as differences 
between the reconstructive methods used. 
 
Patient	selection,	study	design,	and	statistics	
All studies in this thesis are retrospective analyses, with all of its 
associated flaws. In the registration of variables in a retrospective study, 
missing values are unavoidable. Furthermore, data collection is never 
as thorough, and the data of the studies are dependent on the record-
keeping of others at an earlier time point, some of whom were not a 
part of the research projects. 
In Paper II, the results show that many complications are statistically 
significant in the univariate regression analysis, possibly suggesting 
some false-positive results. Statistically significant outcome variables 
are reduced when all applicable confounding factors are adjusted for; 
however, it is possible that more factors would become statistically 
significant if the patient population had been even larger. 
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In Papers II and III, the entire data was studied using both univariate 
and multivariate regression analysis, not separately for each paper. 
This means that all possible confounding factors were accounted for 
and it rules out the possibility that a certain confounding factor in one 
of the papers is the real cause for the results in the other paper. 
Nevertheless, it was decided that the results should be presented in two 
separate original articles due to the vastness of the dataset. 
 
Complications	and	comparison	of	methods	
The results of Paper I show that all reconstructive methods have high 
complication rates. All methods had a higher frequency of 
complications than previously described in the literature. The overall 
incidence of early complications for DIEP was as high as 50%, which is 
considerably higher than has been reported in other 
studies.43,46,56,73,78,79,207,216,217 
One possible explanation may have been differences in the definitions 
of complications and their detailed registration. Generally, there is no 
widely accepted way of defining and registering complications in a 
uniform way and there is large variation in how this is carried out in 
different studies. In this thesis, both relatively minor (but undesirable) 
postoperative outcomes and serious events were included as 
complications. 
Another explanation for the high complication rates in the DIEP group 
may have been that during the study period DIEP reconstructions 
were a relatively novel method in Sweden, and the reconstructions 
were performed by microsurgeons at the beginning of their 
microsurgical learning curve. A study has been published indicating 
improvement of complications in this group of patients during the 
study period,207 but the registration of complications in that paper is 
completely different than in Paper I. 
The analysis in Paper I shows that the DIEP group had a generally 
higher BMI than the other groups. It is known that obesity causes a 
higher frequency of complications compared to rates in normal weight 
individuals,218 which could also explain the higher frequency of 
complications in the DIEP group. The results of this thesis show that 
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BMI is one of the key patient-related factors that affect postoperative 
complications. 
There were also considerable differences in complications between the 
LTDF and EXP groups, particularly regarding the higher incidence of 
early local complications, such as skin necrosis in the LTDF group, 
which was not seen in the expander group. An explanation for the 
difference may be the generally higher BMI in patients in the LTDF 
group than in patients in the EXP group. Additionally, patients in the 
LTDF group had a significantly higher rate of radiotherapy than in the 
EXP group, which also could be a cause of the LTDF group’s higher 
rates of postoperative complications.219-221 
 A considerable number of patients in the implant reconstruction 
groups had received radiotherapy; from 16.2% in the EXP group to 
89.4% in the LD group. The risk of capsular contracture has been 
reported to be high in irradiated implant-based reconstructions, which 
can lead to poor cosmetic results, pain,57,61,68,104,110,111,202 increased risk 
of infection and subsequent implant extraction.57,103 On the other 
hand, in comparison with other studies,107,117,222 the rate of capsular 
contraction in this study was relatively low. 
 
The	search	for	independent	risk	factors	for	
complications	
In Paper II, it was established that both blood loss during surgery and 
duration of surgery were independent risk factors for postoperative 
complications. Long duration of surgery has been found to be an 
independent risk factor for thromboembolism, hematoma, and 
persistent pain in other specialities;223,224 however, several studies in the 
field of plastic surgery have failed to find a relationship between the 
duration and postoperative complications.225-227 Nevertheless, the 
results of Paper II are in agreement with other studies, showing 
prolonged duration of surgery as a risk factor for breast expander 
loss,90,91 wound infection228 and flap failure.93,94,229 Regarding blood 
loss, Lymperopoulos et al. did not find a significant correlation between 
several patient characteristics and blood loss, but did find a high 
correlation between the duration of surgery and complications.93 The 
results of this thesis are to a certain degree also in line with two other 
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studies, where a relationship between the need for transfusion and 
complications was evident, but at the same time showed no significant 
correlation between blood loss and various patient characteristics.75,93 
The results of Paper II also demonstrate that in addition to keeping 
surgery duration to a minimum, meticulous surgical technique to 
minimize blood loss is important. 
The factors of blood loss and duration of surgery are highly associated 
with the increased skill of the surgeons. It is well established that the 
experience of the surgeon is associated with a low frequency of 
complications.101,230,231 However, in Paper II, no correlation was seen 
between the experiences of the eight surgeons (resident, consultant 
without extensive experience, consultant with extensive experience). 
There could be several explanations for these results. Firstly, the 
accurate methodology of registering all postoperative occurrences as 
complications gives no room for grading the severity of each 
complication. More experienced surgeons may have had complications 
of a milder degree than less experienced surgeons. Secondly, more 
experienced surgeons may have operated on patients for whom the 
preconditions for successful results were more complicated. Thirdly, 
there is a certain bias in the distribution of cases between the surgeons, 
in which only two of them carried out all of the microsurgical 
reconstructions besides the other methods, while the others only 
performed the non-microsurgical reconstructions. Furthermore, in the 
study, no attempt was made to evaluate if there were differences in the 
cosmetic results between more and less experienced surgeons. 
In the study of Paper III, we also found that smoking, increased BMI 
and a history of radiotherapy were closely associated with several 
postoperative complications, both early and late, irrespective of 
reconstruction method. Interestingly, smoking was associated with 
several early complications (early overall complications, early 
administration of antibiotics, early overall local complications and early 
skin necrosis), but only one late complication (late resurgery). Increased 
BMI affected both early complications (early overall complications, 
early administration of antibiotics and early resurgery) and late 
complications (late overall complications, late signs of infection, late 
administration of antibiotics and late fat necrosis). A history of 
radiotherapy, on the other hand, generally affects late complications 
(late overall complications, late administration of antibiotics, late 
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overall local complications and late fat necrosis), but also has some 
effect on early complications (early administration of antibiotics and 
early overall local complications). Additionally, when the different 
independent risk factors were combined, the risks increased 
significantly. 
The same significant independent risk factors found in Paper III have 
been previously identified, both in plastic surgery and in other surgical 
specialities.71,72,91,100,128,132,152,218,232 However, the advantage of the 
study of Paper III is the evaluation of four different reconstruction 
methods with the same criteria for complications. This is the first study 
on a large group of patients where the association between an extensive 
collection of patient-related factors and meticulously registered 
postoperative complications was studied using the same definition of 
complications applied to all reconstruction methods, showing that the 
increases in risk were independent of the method. The large number of 
patients also allows adjustment for all confounding factors, providing 
independent risk factors and the construction of the solid risk models as 
seen in Figs 14-19. Consequently, the statistically significant 
associations are true associations, unbiased by operation method or 
patient determinants acting as confounding factors in the model. 
Also of interest are the negative findings of Paper III. Hormone and 
chemotherapy seemed not to affect complication rates after breast 
reconstruction, which is in agreement with most other studies,53,82,103 
but in conflict with a study by Tallet, stating that chemotherapy is a 
risk factor for complications.109 Additionally, age seems to not have an 
association with postoperative complications, besides a protective effect 
against early seroma. History of chemotherapy, adjuvant hormone 
therapy, and concurrent morbidity (diabetes, hypothyroidism, 
cardiovascular disease, history of thromboembolism, coagulopathy, 
rheumatic disease, neurologic disease, renal disease, liver disease, or 
lung disease) had no association with any of the registered 
complications. 
Radiotherapy for breast cancer is still one of the most effective 
treatments to increase survival for many types of breast cancer.31,32 
Radiotherapy inevitably damages the tissue, and as long as the modus 
of radiotherapy is unchanged, a post-radiation breast reconstruction 
will be more challenging. Most studies find that radiotherapy in an 
implant-based reconstruction increases complications and late failure 
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rates. The results of the study of Paper III show as well that history of 
radiotherapy doubles the risk for any local complications and the 
results of increased risk are in line with similar studies.57,61,68,85,103-
112,116,118,120 
The aim of a successful breast reconstruction is to make the patient 
satisfied with the breast, even though it is never of the same quality or 
sensation compared to before the mastectomy or the contralateral 
healthy breast. One of the key elements in patient satisfaction is safety 
during the procedure. As noted before, it is well established that 
postoperative complications influence patient satisfaction.57,63,64 
Therefore it is essential to minimize risks during the surgical 
procedure. In order to make an individual assessment of each patient, 
Paper III contains important information on deciding the best 
reconstruction method. 
 
Ethical	considerations	
The obviously increased risk associated with smoking and high BMI 
posits the question of whether health care providers should demand 
that the patients cease smoking and adapt to normal BMI before 
surgery. Even if high BMI and smoking can be a relative 
contraindication for surgery, the question can be raised of whether it 
can be considered discriminatory to deny certain patients breast 
reconstruction. It is quite simple to require that patients cease smoking 
before surgery because of the availability of various nicotine substitutes. 
However, there is lack of research on the effect of these substitutes on 
flap survival or wound infections after implant reconstructions, for 
example. Additionally, in the present thesis, the results indicate that the 
risks for complications increase with each unit of BMI. There does not 
seem to be any “cut-off” values, neither at the low end, nor at the top 
end. To decide the upper limit is, according to this thesis’ results, 
arbitrary. 
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Health-related	quality	of	life	
As the principal aim of breast reconstruction is to reverse the 
deformity, created by mastectomy, and restore body image and HR-
QoL, traditional clinical outcome measures, such as medical or surgical 
complications, do not suffice in assessing the value of different 
reconstruction methods for each individual patient. There are no 
established guidelines on choosing the best reconstruction method. 
However, patient perspectives and experiences are important when 
choosing a method, and HR-QoL needs to be investigated in a 
systematic way when comparing the advantages of different 
reconstruction methods. 
There are two study designs, in which PROMs are applied: cross-
sectional studies, and follow-up studies. 
Cross-sectional studies collect data which represent a certain degree of 
HR-QoL in a certain group of patients.166 The results of the PROM 
can then be compared with the known average score in the general 
population. As an example, in Paper IV in this thesis, the SF-36 
responses of the study group were compared to 930 age-matched 
controls from the Swedish general population. 
On the other hand, there are follow-up studies, in which measurements 
with the same PROMs are carried out twice or more during a certain 
period of time.166,177,233 The follow-up study can also be used as a cross-
sectional study at a certain moment of time, but is mostly used to 
evaluate changes after a specific intervention. 
In this thesis, the four PROMs (SF-36, EQ-5D, PGWB, and Breast-Q) 
are used as a cross-sectional instrument in the reconstruction groups, in 
which HR-QoL is compared between four groups undergoing breast 
reconstruction with different methods. Breast-Q has both a 
preoperative and a postoperative module, and it can therefore be used 
as a follow-up instrument. Unfortunately, Breast-Q had not yet been 
developed when the patients of the study group had their surgery. 
Furthermore, Breast-Q values for a normal population do not exist to 
the best of the author’s knowledge. Obtaining these values can be a 
basis for further research. 
There are two main findings in Paper IV. Firstly, there were no 
significant differences in most of the domains of the HR-QoL 
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instruments, suggesting that none of the reconstruction methods were 
unquestionably superior to the others. Secondly, the only differences 
between the groups were found in the most specific of the instruments, 
the Breast-Q (with the exception of the vitality domain of SF-36). The 
patients in the DIEP group were more satisfied than the other groups 
in the Breast-Q domains satisfaction with breasts and satisfaction with 
outcome. The domain satisfaction with breasts, measures the perception of 
the breast appearance, and comprises the patient´s opinion on size, 
symmetry, and softness of the breast. The domain satisfaction with 
outcome, measures the overall sense of satisfaction with the outcome 
after undergoing breast reconstruction.234 The patients that underwent 
DIEP were more satisfied with their reconstruction; this is especially 
interesting, given that the patients in this group had a higher frequency 
of complications than the patients in the other groups,67 and it is 
known that postoperative complications tend to decrease satisfaction 
with the outcome of breast reconstruction.57,63,64,210,211 The results of 
the present thesis therefore do not agree with those of previous studies. 
The high satisfaction with breasts in the DIEP group is, however, in line 
with previous studies reporting similarly high rates of satisfaction in this 
group of patients.235-241 Liu et al. compared autologous microsurgical 
reconstruction to expander/implant reconstruction, and showed 
similar results as in Paper IV using Breast-Q, however, only two 
methods were compared.241 Another study by Yueh and co-workers, 
which also shows autologous reconstruction to be superior to implant-
based reconstruction, compared as many methods as in Paper IV, but 
used other outcome measures,238 whereas most studies only evaluate 
DIEP as a single method without comparing it to any other 
methods,45,145,211,216,239,242,243 or comparing it only to the pedicled 
TRAM flap.244-247 
All groups scored similarly on the SF-36, EQ-5D, and PGWB, with the 
exception that the LTDF and EXP groups had a higher score than the 
DIEP group in the vitality domain of the SF-36. This is puzzling and it 
might be interpreted as a Type 1 error, especially as there are no 
significant differences in the vitality domain of the PGWB. The reason 
for the inability of the instruments to detect significant differences is 
that the instruments are probably too generic and not specific enough 
for this group of patients. 
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Additionally, it would have been interesting to have preoperative HR-
QoL data for the groups to be able see whether breast reconstruction 
has a positive effect on HR-QoL or not. 
On analysis of the representativeness of the responders group 
compared to the non-responders group, small differences were found 
in age, follow-up time, smoking, history of chemotherapy and late 
complication rate. Smoking and history of chemotherapy are factors 
that can negatively affect the surgical results. It is possible that they 
cause a non-response bias, whereby a group of patients exposed to 
complications do not wish to answer the questionnaires because of 
dissatisfaction with the results. The shorter follow-up time of the 
responders and higher rate of late complications suggest that patients 
who were still actively thinking about their breast reconstruction were 
more likely to respond to the questionnaires. 
The advantages of Paper IV are its relatively good response rate and 
well-validated generic and specific patient-reported outcome measures. 
The study also includes a greater number of patients compared to that 
of other studies evaluating patient satisfaction after breast 
reconstruction,24,237,239 and is based on the registration of consecutive 
patients during a relatively long period of time. 
However, Paper IV has some limitations. A noticeable limitation is the 
fact that it does not contain baseline data on HR-QoL before breast 
reconstruction. The Breast-Q has modules for both preoperative and 
postoperative evaluation,248 but no values for a normal population. 
Since only non-validated specific questionnaires were in use at the 
time, and the Breast-Q had not been developed, baseline data on this 
group of patients was not available. Nevertheless, postoperative 
patient-reported outcome measurements, alone, do provide valuable 
insights into HR-QoL and patient satisfaction after breast 
reconstruction and can be efficiently utilized to compare reconstruction 
methods. To get a more comprehensive picture, a prospective study 
with randomized selection of reconstruction method, using both the 
preoperative and postoperative questionnaires, would be appropriate. 
The emphasis an individual patient places on the outcome factor 
satisfaction with breasts versus the other outcome factors, such as length of 
recovery or complication rates, needs to be discussed with the patient 
and is an important factor to consider when deciding on the most 
suitable method of breast reconstruction. 
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It is unclear how to interpret the fact that all the reconstruction groups 
score equally, or even higher than the normal population in the 
physical function domain, but, on the other hand, have a lower score 
in the mental health domains. Even if breast cancer is rather common, 
the reference population is probably mostly healthy, having a 
distribution of physical and psychological conditions similar to the 
general population. With this in mind, it probably is the long-term 
consequences of the diagnosis of breast cancer that causes the poorer 
mental health. An uncomplicated interpretation of the results is that 
after full treatment for breast cancer, the patients may completely 
recover physically, but never completely recover mentally. 
The number of patients in Paper IV is larger than other studies 
evaluating patient satisfaction after breast reconstruction24,237,239 and is 
based on the registration of consecutive patients during several years. 
The results generally show a trend towards superior HR-QoL and 
patient satisfaction in the DIEP group, and it is not unlikely that an 
even larger sample of patients would show additional significant 
differences. In Sweden, there is a lifetime guarantee on breast 
reconstructions performed in the public funded health care system. 
Therefore, it is possible that the implant patients need additional 
corrections in the future. However, it takes a DIEP patient 1.7 
procedures until completion, and many of the 0.7 operations are 
because of early complications. In the present thesis, there is no 
analysis carried out on if there generally is shorter time since the 
implant patients have been in the office discussing results, satisfaction 
or late complications, compared with the DIEP group. Analysis of this 
could indicate whether the implant patients are still considering their 
reconstruction or not. 
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6 CONCLUSIONS	
 
1. The frequency of complications is high with all the four 
methods studied, with higher frequencies than in most other 
studies. It is unclear if the reason is the detailed registration of 
complications, and that all occurrences were considered 
adverse events, or if the frequency is truly higher. 
2. The perioperative factors of blood loss during surgery and 
duration of surgery are independent risk factors for 
postoperative complications in breast reconstruction, without 
possible confounding factors being the true reason for the 
association. 
3. The patient-related factors that also are independent risk 
factors for complications in breast reconstruction are previously 
known and they increase the risk significantly when they are 
combined. 
4. The DIEP group were more satisfied according to the Breast-
Q´s domains, satisfaction with breasts and satisfaction with outcome, 
than the other groups, even though the patients in this group 
had higher frequency of complications compared to the 
patients in all of the other groups. 
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7 FUTURE	PERSPECTIVES	
 
To get a more comprehensive picture of the operation methods, a 
prospective study with randomized selection of reconstruction methods 
using both the preoperative and postoperative questionnaires would be 
appropriate. Since 2010, a prospective, randomized study has been 
conducted at the Department of Plastic Surgery, Sahlgrenska 
University Hospital, where irradiated patients are randomized to either 
a DIEP, or an LD, and non-irradiated patients are randomized to 
either LTDF or EXP. At present, the patients of the study have already 
undergone their surgery. Data on early complications has been 
collected and the data is now under analysis. Data on late 
complications are continuously collected, but complete data with as 
long follow-up time as in this thesis is several years ahead. 
When data from the prospective study will be analysed, it is important 
to compare the factors of blood loss and duration of surgery with the 
results of this thesis to evaluate if blood loss, duration of surgery and 
the frequency of complications has decreased. If that is the fact, there is 
even more evidence to conclude that blood loss and duration of surgery 
are important factors for decreasing complication frequency in the 
DIEP group. 
In general, implant based reconstructions have a shorter duration of 
surgery but a larger number of reoperations. One surgical procedure 
has a fixed cost in terms of disposables, instruments, cost of implants, 
more inactive time in the operation theatre (changing from one patient 
to the next), and longer convalescence time. The LD, LTDF, and DI 
methods are planned as one-stage reconstructions, but the results of 
Paper I and II reveal that this is simply not correct. The actual mean 
number of procedures for LD, LDTF, and DI is 2.0, 2.0, and 1.9, 
respectively. Thus, in this patient population, the LD, LTDF, and DI 
are really two stage reconstruction methods. The same value for EXP 
is 2.5, which is a two-stage method from the beginning, and the DIEP, 
with all its complications, is only 1.7. When choosing the reconstructive 
method, this fact needs to be explained to the patients and taken into 
consideration in the decision-making on which methods should be 
offered to the patients.  
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There is a compelling need to study the total cost of the DIEP 
reconstructions compared to the implant based reconstructions. It is 
not impossible that a DIEP flap, which often is considered a much 
more expensive reconstruction method than implant based 
reconstructions, could in the long run be the most cost effective. 
As long as the tissue damage of radiotherapy will not change 
fundamentally, the transfer of non-irradiated tissue to the breast area 
will be necessary, for a high quality breast reconstruction to be made. 
The tissue transfer approach automatically causes the reconstructive 
procedure to be more extensive surgery than the simple removal of the 
breast. The introduction of novel, individually designed, medical 
treatment may possibly decrease the frequency of radiation, which can 
help in the attempts to make breast reconstruction a less extensive 
surgery. 
Breast-Q, which today seems to be the best instrument to measure 
HR-QoL and satisfaction shows, without a doubt, that DIEP patients 
are more satisfied with their reconstruction than patients in the other 
groups, even if this group is more exposed to complications, especially 
early complications. It is interesting to speculate which effect it would 
have if it was possible to significantly reduce complications in this 
group of patients. Is it possible that vitality would not be significantly 
lower in the SF-36? Would it be possible that DIEP patients would 
have a higher score in more domains than just satisfaction with breasts 
and satisfaction with overall outcome in the Breast-Q? If these were the 
results, there would be an even clearer picture pointing in the direction 
that for patients to get the highest gain in HR-QoL, a DIEP should be 
chosen. If this is the fact, the analysis of data from the prospective study 
should reveal it. 
The study design of this thesis is a single-centre study with patients of 
eight surgeons. It is well accepted that surgeons have certain 
preferences in the choice of method for breast reconstruction. In the 
group of patients studied in this thesis, several of the surgeons 
performing the LD, LTDF, and EXP operations were not involved in 
the microsurgical DIEP procedures. This could have biased both 
choice of method, and have effects on the patients’ satisfaction with the 
outcome. In possible future research, including patients from several 
clinics and more surgeons could help minimize potential confounding 
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effects of the clinic where the reconstructions take place and the 
surgeon performing the procedure. 
Another aspect of implant reconstructions is that no one knows the real 
lifetime of the newest generation of silicone implants, which did not 
exist in the market, until about 15 years ago; therefore, no patients 
have had them longer than that. Even though, until now, there have 
not been any notable quality problems, it is unknown what will happen 
in 20 or 40 years. It is not impossible that tissue engineering can 
contribute with products that make silicone implants obsolete, but that 
also means that patients with implants have to have at least one 
additional surgical procedure, creating a filling under the skin to 
restore the breast shape. 
 
All results combined indicate that a DIEP reconstruction with duration 
of surgery and blood loss kept to a minimum, in a non-irradiated, non-
smoking, healthy patient with a normal BMI, has the best chance to 
result in an optimal quality of life after mastectomy and breast 
reconstruction. 
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